Malignant neoplasm of pancreas

C3_PANCREAS

Malignant Pancreatic Neoplasm: A primary or metastatic malignant tumor involving the pancreas. Representative examples include carcinoma and lymphoma. -- 2003

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Cause of death: ICD-10 — C25 Cause of death: ICD-9 — 157 Cause of death: ICD-8 — 157 Cancer registry: Topography ICD-O-3 — C25 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — 3 2 out of 7 registries used, show all original rules.	2800
4. Check minimum number of events None	2800
5. Include endpoints None	2800
6. Filter based on genotype QC (FinnGen only)	2723

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF9

NAME	C3_PANCREAS
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C25
COD_ICD_9	157
COD_ICD_8	157
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C25
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of pancreas based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2723	1135	1588
Unadjusted period prevalence (%)	0.59	0.40	0.73
Median age at first event (years)	71.69	71.56	71.78

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2800: Matched controls
28000

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

C25.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of pancreas

+∞

311.4

293

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

+∞

307.7

705

130

Kela drug reimbursment

Malignant tumour

+∞

307.7

1783

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

21.4

307.7

325

171

L03AA02

ATC

filgrastim; parenteral

166.5

307.7

201

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

17.2

307.7

292

188

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

307.7

1576

R4190

NOMESCO Finland

Nutritional therapy

18.4

307.7

300

181

WX302

NOMESCO Finland

Thoracal epidural anesthesy

25.6

307.7

486

228

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

132.4

307.7

791

A03FA01

ATC

metoclopramide; systemic, rectal

21.7

307.7

1607

1633

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

+∞

307.7

1267

C25.2

ICD-10 Finland

Malignant neoplasm: Tail of pancreas

+∞

307.7

362

JN4AD

NOMESCO Finland

Body CT examination

10.9

307.7

625

722

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

36.3

307.7

209

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

4667.2

307.7

727

UJK02

NOMESCO Finland

ERCP

26.3

307.7

633

308

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

+∞

307.7

470

A04AA01

ATC

ondansetron; systemic, rectal

28.9

307.7

587

255

K83.1

ICD-10 Finland

Obstruction of bile duct

82.6

307.7

497

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

79.5

307.7

919

171

8000/3-C25.9

ICD-O-3

Neoplasm, malignant of pancreas, NOS

+∞

307.7

683

A06AH03

ATC

naloxegol; oral

60.7

307.7

229

JN4CD

NOMESCO Finland

Very extensive body CT

27.2

307.7

347

145

H02AB02

ATC

dexamethasone; systemic

117.9

307.7

1008

133

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

18.6

307.7

545

360

JLC30

NOMESCO Finland

Pancreatoduodenectomy

963.4

307.7

412

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

112.2

307.7

468

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

+∞

307.7

540

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

28.9

307.7

253

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

155.2

307.7

329

JN4BD

NOMESCO Finland

Extensive body CT

11.9

307.7

582

606

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

760.7

307.7

502

L01BC06

ATC

capecitabine; oral

+∞

307.7

563

Z51.5

ICD-10 Finland

Palliative care

35.6

307.7

1200

578

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

53.6

307.7

500

113

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

38.0

307.7

405

124

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

307.7

467

N02AA05

ATC

oxycodone; systemic

12.4

307.7

1578

2644

A04AA02

ATC

granisetron; systemic, transdermal

1804.2

307.7

872

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

117.5

307.7

1067

146

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

27.3

307.7

355

148

JK3BT

NOMESCO Finland

Catherisation of bile duct with X-ray guidance

104.6

306.5

158

TPX10

NOMESCO Finland

Implantation of vascular injection port

14.7

298.1

276

207

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

2905.0

288.4

274

JJ1CE

NOMESCO Finland

Liver, bile duct and pancreas endoscopic ultrasound examination

76.5

283.2

152

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

33.7

275.8

177

WZC00

NOMESCO Finland

Treatment plan or consultation

4.0

274.3

1197

4388

D76

ICPC

Malignant neoplasm pancreas

953.3

269.3

260

JAH01

NOMESCO Finland

Laparoscopy

11.6

268.5

288

273

K83.0

ICD-10 Finland

Cholangitis

16.4

260.7

225

148

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

7.8

257.3

384

557

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

84.0

256.8

136

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

22.2

256.0

191

WF002

NOMESCO Finland

Radical radiotherapy

70.3

246.5

134

JN3AD

NOMESCO Finland

Abdominal CT examination

5.1

243.9

609

1452

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

5.8

243.0

502

1013

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

774.0

221.1

215

R18

ICD-10 Finland

Ascites

14.3

217.7

202

151

JK3NB

NOMESCO Finland

Percutaneous transhepatic cholangiography

89.7

213.2

112

8140/3-C25.0

ICD-O-3

Adenocarcinoma, NOS, of head of pancreas

+∞

211.2

200

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

+∞

203.7

193

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

9.2

203.0

257

304

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

85.5

202.4

107

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

198.3

188

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

6.0

188.3

361

673

JMA10

NOMESCO Finland

Transabdominal total splenectomy

66.8

187.9

103

B01AB10

ATC

tinzaparin; parenteral

5.1

185.9

432

958

WW500

NOMESCO Finland

Blood transfusion

10.1

183.6

215

229

WZC30

NOMESCO Finland

Teaching

4.1

180.1

583

1676

JN3BD

NOMESCO Finland

Extensive abdominal CT

4.5

170.8

478

1229

A04AA55

ATC

palonosetron, combinations; systemic

+∞

168.5

160

L03AA13

ATC

pegfilgrastim; parenteral

582.0

168.0

165

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

166.3

158

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.8

165.3

613

1930

JKE25

NOMESCO Finland

Endoscopic external drainage of bile duct

192.2

157.5

163

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

154.6

147

8000/3-C25.0

ICD-O-3

Neoplasm, malignant of head of pancreas

+∞

154.6

147

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

153.6

146

C61

ICD-10 Finland

Malignant neoplasm of prostate

271.6

152.0

154

JKE22

NOMESCO Finland

Endoscopic extraction of foreign body from bile duct

33.5

151.5

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

11.0

150.7

164

157

D13.6

ICD-10 Finland

Benign neoplasm: Pancreas

22.4

149.1

110

8500/3-C25.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of pancreas, NOS

+∞

147.2

140

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

27.4

143.5

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.6

140.9

541

1730

JLC10

NOMESCO Finland

Distal pancreatectomy

251.0

140.5

143

JL1AT

NOMESCO Finland

Biopsy of pancreas with ultrasound guidance

1387.6

136.6

132

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

136.6

130

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

12.1

132.4

135

117

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

32.4

131.5

A10AB05

ATC

insulin aspart; parenteral

3.9

129.9

434

1259

C25

ICD-10 Finland

Malignant neoplasm of pancreas

+∞

127.0

121

XX3DW

NOMESCO Finland

Time consuming IT work

5.2

126.3

278

582

R50.9

ICD-10 Finland

Fever, unspecified

3.2

125.1

589

2129

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

20.5

124.1

JK4ZT

NOMESCO Finland

Percutaneous transhepatic implantation of bile duct prothesis

613.8

120.1

118

C25.4

ICD-10 Finland

Malignant neoplasm: Endocrine pancreas

+∞

119.6

114

JDE00

NOMESCO Finland

Gastrojejunostomy

312.9

118.1

119

SPAT1109

SPAT

Analgesia with portable analgesic pump

27.6

114.6

L02AE02

ATC

leuprorelin; implant, parenteral

59.5

114.3

B01AB05

ATC

enoxaparin; parenteral

2.5

108.7

1029

5300

WX004

NOMESCO Finland

Patient-controlled sedation

28.4

106.8

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

14.6

106.1

A10AE04

ATC

insulin glargine; parenteral

3.2

105.2

492

1758

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

8.0

103.8

143

186

ZX120

NOMESCO Finland

Intravenous

3.8

102.2

337

962

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

18.3

102.0

JKE32

NOMESCO Finland

Endoscopic dilatation of bile duct

21.1

100.7

116

Kela drug reimbursment

Prostate cancer

+∞

100.6

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

51.0

95.3

115

Kela drug reimbursment

Breast cancer

+∞

94.3

A04AD12

ATC

aprepitant; systemic

478.5

93.9

WF049

NOMESCO Finland

Radiotherapy of metastasis

467.7

91.8

B01AB04

ATC

dalteparin; parenteral

4.3

88.5

242

601

JAH00

NOMESCO Finland

Laparotomy

6.1

88.5

157

268

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

86.9

8500/3-C25.0

ICD-O-3

Infiltrating duct carcinoma, NOS, of head of pancreas

+∞

86.9

A79

ICPC

Malignancy NOS

181.6

84.7

J01MA12

ATC

levofloxacin; systemic

2.5

84.0

685

3236

TPH07

NOMESCO Finland

Cathetrisation of artery

3.0

82.1

425

1595

H01CB03

ATC

lanreotide; parenteral

821.8

81.9

L01AX03

ATC

temozolomide; systemic

+∞

80.6

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

30.0

80.0

ZX122

NOMESCO Finland

Intra-arterial

20.1

79.2

D70.82

ICD-10 Finland

Drug-induced neutropenia

24.8

79.2

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

387.7

76.2

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

8.4

75.9

100

123

TPH04

NOMESCO Finland

Cathetrisation of vein

2.3

73.9

708

3567

K86.9

ICD-10 Finland

Disease of pancreas, unspecified

15.1

73.5

JLC11

NOMESCO Finland

Laparoscopic distal pancreatectomy

192.6

72.5

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

72.2

PHN73

NOMESCO Finland

Reconstruction of superior mesenteric or portal vein

716.2

71.4

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

71.4

1016

5979

L02BG04

ATC

letrozole; oral

26.2

70.7

WX610

NOMESCO Finland

Patient controlled analgesia

20.4

70.6

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

5.8

70.3

131

234

8140/3-C25.2

ICD-O-3

Adenocarcinoma, NOS, of tail of pancreas

+∞

70.1

PJA12

NOMESCO Finland

Sentinel node biopsy

356.0

69.9

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

9.1

69.8

WX402

NOMESCO Finland

General anaesthesia

2.5

69.3

501

2219

191

Kela drug reimbursment

Erlotinib

+∞

69.0

8240/3-C25.9

ICD-O-3

Neuroendocrine tumor, NOS, of pancreas, NOS

+∞

69.0

103

Kela drug reimbursment

Diabetes, insulin-treated

2.0

68.5

1072

6509

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

6.3

67.6

115

188

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.4

67.4

566

2681

N02AA01

ATC

morphine; systemic, rectal

7.3

67.1

100

142

JK3SB

NOMESCO Finland

Endoscopic retrorade cholangiography

25.1

66.8

A02BC02

ATC

pantoprazole; systemic

2.1

65.8

1925

14473

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

15.7

65.8

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

653.1

65.2

N02AX02

ATC

tramadol; systemic, rectal

2.0

63.2

1284

8476

K86.8

ICD-10 Finland

Other specified diseases of pancreas

21.7

63.1

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

62.7

1CD01, ,

NOMESCO Finland

+∞

60.6

JL2AT

NOMESCO Finland

Cytology of pancreas with ultrasound guidance

600.7

59.9

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.9

59.7

186

506

A98

ICPC

Health maint/preventive medicine

0.5

59.1

1831

22086

K85.8

ICD-10 Finland

Other acute pancreatitis

10.5

58.9

A06AD11

ATC

lactulose; oral

2.2

58.6

632

3304

E13.8

ICD-10 Finland

Other specified diabetes mellitus, with unspecified complications

23.7

58.3

WF004

NOMESCO Finland

Palliative radiotherapy

579.8

57.9

8010/3-C25.9

ICD-O-3

Carcinoma, NOS, of pancreas, NOS

+∞

57.5

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

57.5

K86.1

ICD-10 Finland

Other chronic pancreatitis

8.3

57.3

8249/3-C25.9

ICD-O-3

Neuroendocrine tumor, grade 2 of pancreas, NOS

+∞

55.4

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

55.4

8140/3-C25.1

ICD-O-3

Adenocarcinoma, NOS, of body of pancreas

+∞

54.3

C25.7

ICD-10 Finland

Malignant neoplasm: Other parts of pancreas

+∞

54.3

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

9.6

54.3

HAB40

NOMESCO Finland

Wedge excision of mammary gland

14.9

52.8

JK3NT

NOMESCO Finland

Percutaneous transhepatic dilatation of bileducts

68.0

52.3

JLC40

NOMESCO Finland

Total pancreatoduodenectomy

270.8

52.3

D13.7

ICD-10 Finland

Benign neoplasm: Endocrine pancreas

183.5

52.1

H01CB02

ATC

octreotide; parenteral

140.2

52.0

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.7

51.5

173

495

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.2

49.5

472

2334

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

49.5

908

5683

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

48.4

636

3551

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

11.9

48.1

JN7AQ

NOMESCO Finland

Somatostatin receptor SPET med low dose CT

+∞

47.0

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

46.0

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

3.9

45.6

138

367

L01XE03

ATC

[U] erlotinib

+∞

44.9

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

18.2

44.7

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

444.6

44.3

JK3FT

NOMESCO Finland

Exchange of bile duct catheter with radiological guidance

119.5

43.9

WW200, ,

SPAT

0.3

43.8

141

4089

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.9

42.6

219

809

HAC20

NOMESCO Finland

Total mastectomy

114.3

41.8

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.7

41.5

134

373

ZX090

NOMESCO Finland

Other technic of radiotherapy

68.2

41.1

8000/3-C25.1

ICD-O-3

Neoplasm, malignant of body of pancreas

+∞

40.7

N05BA06

ATC

lorazepam; systemic, sublingual

2.9

40.6

208

766

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.3

40.6

118

3629

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

403.2

40.2

XX7JT

NOMESCO Finland

Somatostatin isotope ablative therapy

+∞

39.7

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

4.1

38.7

109

275

K83.9

ICD-10 Finland

Disease of biliary tract, unspecified

11.6

38.7

1570A

ICD-9 Finland

Malignant neoplasm of pancreas, Head of pancreas

+∞

38.6

JN5ER

NOMESCO Finland

PET-CT of receptors in whole body

51.9

38.6

A41.8

ICD-10 Finland

Other specified sepsis

4.4

38.6

233

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.8

38.5

793

5070

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

4.9

38.2

174

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

37.6

JFA65

NOMESCO Finland

Endoscopic insertion of ileum stent

+∞

37.6

Z31.5

ICD-10 Finland

Genetic counselling

4.4

37.4

226

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

36.5

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

3.4

35.9

134

410

WF003

NOMESCO Finland

Adjuvant radiotherapy

187.4

35.8

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

187.4

35.8

JLD12

NOMESCO Finland

Endoscopic drainage of pancreatic pseudocyst

98.9

35.8

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

+∞

35.5

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

35.5

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.9

35.4

555

3251

TJA10

NOMESCO Finland

Laparocentesis

79.2

34.9

E34.0

ICD-10 Finland

Carcinoid syndrome

96.3

34.8

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

+∞

34.4

JDH35

NOMESCO Finland

Endoscopic insertion of duodenal stent

341.3

34.0

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

341.3

34.0

KCD02

NOMESCO Finland

Transurethral resection of bladder

9.2

33.9

L02BA01

ATC

tamoxifen; oral

93.8

33.8

L02BB03

ATC

bicalutamide; oral

+∞

33.4

WX002

NOMESCO Finland

Sedation and analgesia

1.8

33.1

565

3394

N05AD01

ATC

haloperidol; systemic

3.1

32.9

143

480

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

75.1

32.9

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

172.0

32.8

R11

ICD-10 Finland

Nausea and vomiting

2.3

32.5

258

1172

C10AA07

ATC

rosuvastatin; oral

0.5

32.5

373

6512

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

32.3

197

Kela drug reimbursment

Sunitinib

+∞

32.3

JDE01

NOMESCO Finland

Laparoscopic gastroenterostomy

+∞

32.3

JLA00

NOMESCO Finland

Exploration of pancreas

320.6

31.9

ZX070

NOMESCO Finland

Intensity modified radiotherapy

166.9

31.7

Y77

ICPC

Malignant neoplasm prostate

114.7

31.7

158

Kela drug reimbursment

Everolimus

+∞

31.3

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

316.3

30.9

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

30.3

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

+∞

30.3

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

12.1

29.9

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

45.5

29.6

I81

ICD-10 Finland

Portal vein thrombosis

10.8

29.6

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

29.2

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

32.1

29.1

JKA20

NOMESCO Finland

Cholecystectomy

3.2

29.0

116

371

XX9AN

NOMESCO Finland

Complementary isotope examination or additional picture

151.6

28.7

M79.6

ICD-10 Finland

Pain in limb

0.6

28.6

496

7725

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

28.6

1249

9512

P20

ICPC

Memory disturbance

0.4

28.5

155

3593

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

28.2

WVA20

NOMESCO Finland

Medicine administration

3.9

28.0

222

JMA11

NOMESCO Finland

Laparoscopic total splenectomy

78.5

27.8

D44.8

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement

78.5

27.8

ZXE40

NOMESCO Finland

More than seven and less than nine hours

4.0

27.4

203

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.6

27.1

JKD20

NOMESCO Finland

Anastomosis of bile duct to jejunum

273.6

26.8

WX892

NOMESCO Finland

Monitored bed care

2.2

26.4

240

1152

HA1AA

NOMESCO Finland

X-ray mammography

3.5

26.2

261

N06DX01

ATC

memantine; oral

0.3

26.2

2203

C26.9

ICD-10 Finland

Malignant neoplasm: Ill-defined sites within the digestive system

+∞

26.1

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

5.7

26.0

I25.1

ICD-10 Finland

Atherosclerotic heart disease

0.6

25.9

430

6821

C50.99

ICD-10 Finland

Breast, unspecified

263.0

25.7

K86.3

ICD-10 Finland

Pseudocyst of pancreas

8.2

25.6

ZX121

NOMESCO Finland

Central venous catheter

33.4

25.6

JLW98

NOMESCO Finland

Other transluminal endoscopic operation on pancreas

33.4

25.6

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

4.3

25.1

150

8000/3-C25.2

ICD-O-3

Neoplasm, malignant of tail of pancreas

+∞

25.0

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

25.0

D37.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Stomach

9.8

25.0

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

3.0

24.8

112

385

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

43.3

24.6

WPB10

NOMESCO Finland

Making a convalescent care decision

27.8

24.5

C10AX09

ATC

ezetimibe; oral

0.4

24.0

135

3102

R93.3

ICD-10 Finland

Abnormal findings on diagnostic imaging of other parts of digestive tract

9.1

23.9

JLA10

NOMESCO Finland

Biopsy of pancreas

68.0

23.8

J94.8

ICD-10 Finland

Other specified pleural conditions

4.1

23.8

165

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

0.6

23.2

638

8978

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.9

23.1

317

1764

A10BA02

ATC

metformin; oral

1.5

23.0

916

6743

M25.5

ICD-10 Finland

Pain in joint

0.5

23.0

296

5081

340

Kela drug reimbursment

Everolimus

+∞

22.9

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

22.9

Z02.4

ICD-10 Finland

Examination for driving licence

0.6

22.7

397

6255

A10AE05

ATC

insulin detemir; parenteral

2.3

22.7

183

835

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.2

22.6

210

1016

J01MA02

ATC

ciprofloxacin; systemic

1.5

22.5

1048

7970

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.8

22.4

112

407

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.0

22.2

332

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

3.9

22.2

165

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

21.6

22.1

ZZR00

NOMESCO Finland

Flap of skin

7.1

22.1

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

22.0

813

5878

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

+∞

21.9

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

21.9

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

+∞

21.9

YJ1CD

NOMESCO Finland

Very extensive CT examination of abdomen for dose design of radiotherapy

+∞

21.9

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

21.9

K31.5

ICD-10 Finland

Obstruction of duodenum

25.2

21.7

T73

ICPC

Neoplasm endocrine other/unspecified

221.7

21.6

SAA01

NOMESCO Finland

Simple examination of mouth

0.7

21.6

1036

13052

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.5

21.3

133

541

ZXE20

NOMESCO Finland

More than three and less than five hours

1.8

21.3

342

1997

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

5.5

21.2

G30.1

ICD-10 Finland

Alzheimer disease with late onset

0.3

21.2

1777

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.8

21.2

110

408

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

0.6

20.9

469

6967

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.6

20.9

364

5764

8249/3-C25.2

ICD-O-3

Neuroendocrine tumor, grade 2 of tail of pancreas

+∞

20.9

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

77.4

20.7

I50.9

ICD-10 Finland

Heart failure, unspecified

0.5

20.7

228

4121

KA1FN

NOMESCO Finland

Isotope renography

8.7

20.7

JLC00

NOMESCO Finland

Excision of lesion of pancreas

211.5

20.6

T90

ICPC

Diabetes non-insulin dependent

1.5

20.1

715

5109

C10AA05

ATC

atorvastatin; oral

0.7

20.1

763

10117

JN1AD

NOMESCO Finland

CT examination of upper part of abdomen

8.0

20.0

SAA02

NOMESCO Finland

Basic examination of mouth

0.7

19.9

883

11367

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

19.8

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

19.8

WPA16

NOMESCO Finland

Extensive demanding palliative symptom assessment and treatment

105.8

19.6

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

201.4

19.6

TJA40

NOMESCO Finland

Percutaneous local drainage of peritoneal cavity

201.4

19.6

JLB28

NOMESCO Finland

Endoscopic internal drainage of pancreatic duct

24.8

19.5

NK6AN

NOMESCO Finland

Total body bone isotope imaging

19.5

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

6.2

19.4

L15

ICPC

Knee symptom/complaint

0.5

19.2

241

4196

E14.8

ICD-10 Finland

Unspecified diabetes mellitus, with unspecified complications

7.9

19.2

SPAT1053

SPAT

Memory test

0.5

19.1

202

3707

TPX15

NOMESCO Finland

Removal of vascular injection port

20.2

19.0

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.9

19.0

142

EB1VA, ,

NOMESCO Finland

0.3

19.0

1585

JFC00

NOMESCO Finland

Entero-enterostomy

55.4

18.9

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

18.8

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

18.8

8246/3-C25.9

ICD-O-3

Neuroendocrine carcinoma, NOS, of pancreas, NOS

+∞

18.8

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

18.8

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

18.8

L01XE10

ATC

[U] everolimus

+∞

18.8

Z01.2

ICD-10 Finland

Dental examination

0.6

18.7

490

7057

B03XA02

ATC

darbepoetin alfa; parenteral

3.5

18.6

182

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

4.5

18.5

K86.2

ICD-10 Finland

Cyst of pancreas

4.5

18.2

K85

ICD-10 Finland

Acute pancreatitis

3.3

18.2

214

K56.7

ICD-10 Finland

Ileus, unspecified

3.4

18.1

190

ZX080

NOMESCO Finland

Image guided radiotherapy

+∞

17.7

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

+∞

17.7

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

17.7

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

+∞

17.7

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

17.7

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

17.7

325

Kela drug reimbursment

Erlotinib

+∞

17.7

322

Kela drug reimbursment

Sunitinib

+∞

17.7

SDA03

NOMESCO Finland

Periodontal treatment

0.6

17.7

398

5952

WPA13

NOMESCO Finland

Palliative consultation

14.6

17.6

D77

ICPC

Malignant digestive neopl other/NOS

95.7

17.6

T89

ICPC

Diabetes insulin dependent

2.6

17.6

103

407

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

4.8

17.5

V03AF03

ATC

calcium folinate; systemic

181.1

17.5

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

0.5

17.4

232

3980

R4110, ,

SPAT

0.2

17.3

1303

H25.1

ICD-10 Finland

Senile nuclear cataract

0.7

17.2

540

7511

SPAT1262

SPAT

Handing over of treatment supplies

1.6

17.2

501

3411

ZXE00

NOMESCO Finland

One hour or less

1.4

17.1

878

6720

A41.9

ICD-10 Finland

Sepsis, unspecified

2.4

17.1

122

529

XX1XW

NOMESCO Finland

Extensive written report from radiologist

3.4

17.0

183

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

7.6

17.0

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

63.7

16.7

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

0.7

16.7

682

9016

L03

ICPC

Low back symptom/complaint

0.6

16.7

281

4526

1579X

ICD-9 Finland

Malignant neoplasm of pancreas, Pancreas, part unspecified

+∞

16.7

L01CB01

ATC

etoposide; systemic

+∞

16.7

C24.9

ICD-10 Finland

Malignant neoplasm: Biliary tract, unspecified

+∞

16.7

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

16.7

C24.1

ICD-10 Finland

Malignant neoplasm: Ampulla of Vater

+∞

16.7

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

16.7

C25.3

ICD-10 Finland

Malignant neoplasm: Pancreatic duct

+∞

16.7

N06DA02

ATC

donepezil; oral

0.3

16.7

1639

K02.1

ICD-10 Finland

Caries of dentine

0.7

16.6

763

9871

C10AC01

ATC

colestyramine; oral

3.0

16.5

254

N05CF01

ATC

zopiclone; oral

1.4

16.4

868

6665

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

23.2

16.4

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

4.4

16.4

Z76.0

ICD-10 Finland

Issue of repeat prescription

0.5

16.3

188

3372

K85.0

ICD-10 Finland

Idiopathic acute pancreatitis

5.2

16.3

L13

ICPC

Hip symptom/complaint

0.5

16.3

192

3421

WX600

NOMESCO Finland

Single shot through catheter

6.6

16.2

SFA10

NOMESCO Finland

One-surface restoration

0.7

16.2

717

9351

R4110

NOMESCO Finland

Physiotherapy

1.5

16.1

636

4617

XF612

NOMESCO Finland

Measurement of central venous pressure

24.6

16.0

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

13.6

16.0

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

0.6

15.9

389

5729

ZX112

NOMESCO Finland

Subcutaneous

5.4

15.9

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.5

15.7

405

WB101

NOMESCO Finland

Simple cytostatic neoadjuvant therapy

+∞

15.6

C17.0

ICD-10 Finland

Malignant neoplasm: Duodenum

+∞

15.6

L01EG02

ATC

everolimus; oral

+∞

15.6

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

15.6

L01XE04

ATC

[U] sunitinib

+∞

15.6

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

85.6

15.6

E89.1

ICD-10 Finland

Postprocedural hypoinsulinaemia

85.6

15.6

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

160.9

15.5

L02BG03

ATC

anastrozole; oral

160.9

15.5

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

3.6

15.4

136

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.3

15.3

175

N02AA03

ATC

hydromorphone; systemic, rectal

28.8

15.2

SDA02

NOMESCO Finland

Periodontal treatment, brief

0.6

15.0

373

5486

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

0.7

14.9

520

7120

WPA45

NOMESCO Finland

Continuous drug infusion in palliative care

31.9

14.8

D13

ICPC

Jaundice

31.9

14.8

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

18.5

14.7

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

0.6

14.6

208

3520

PHC71

NOMESCO Finland

Suture of mesenteric or portal vein

+∞

14.6

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

14.6

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

14.6

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

14.6

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

14.6

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

14.6

D70.89

ICD-10 Finland

Neutropenic splenomegaly

5.1

14.6

SPAT1255

SPAT

Intravenous administration of medicine

1.9

14.5

190

1038

JN4DD

NOMESCO Finland

Scout CT scan of torso

150.8

14.5

C50

ICD-10 Finland

Malignant neoplasm of breast

150.8

14.5

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

14.4

893

7021

SPAT1290

SPAT

Preparation of deceased person

22.4

14.2

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

2.8

14.1

266

WX100

NOMESCO Finland

Conjunctival surface anesthesia

0.5

14.0

143

2676

JN6AD

NOMESCO Finland

CT of torso and neck

5.4

14.0

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

15.8

13.9

E16.10

ICD-10 Finland

Hyperinsulinism

53.6

13.8

R01AD58

ATC

fluticasone, combinations; nasal

0.5

13.8

156

2824

L01EX01

ATC

sunitinib; oral

+∞

13.5

8500/3-C25.1

ICD-O-3

Infiltrating duct carcinoma, NOS, of body of pancreas

+∞

13.5

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

13.5

PHN72

NOMESCO Finland

Plastic repair of superior mesenteric or portal vein

+∞

13.5

8240/3-C25.2

ICD-O-3

Neuroendocrine tumor, NOS, of tail of pancreas

+∞

13.5

8500/3-C25.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of tail of pancreas

+∞

13.5

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

13.5

JKD00

NOMESCO Finland

Anastomosis of gallbladder to jejunum

140.7

13.5

JN7AN

NOMESCO Finland

Somatostatin receptor isotope imaging

140.7

13.5

C90.0

ICD-10 Finland

Multiple myeloma

140.7

13.5

SPAT1088

SPAT

Blood transfusion

6.1

13.4

WX320

NOMESCO Finland

Spinalanesthesy

0.6

13.4

299

4518

R83

ICPC

Respiratory infection other

0.5

13.3

138

2571

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

21.2

13.3

L08

ICPC

Shoulder symptom/complaint

0.6

13.2

237

3779

UJK12

NOMESCO Finland

Peroral cholangioscopy

13.8

13.2

XX2RW, ,

NOMESCO Finland

6.2

12.9

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

0.6

12.9

278

4240

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.0

12.9

DAX08

NOMESCO Finland

Fitting of hearing aid

0.3

12.9

1067

JLB12

NOMESCO Finland

Transduodenal endoscopic incision of pancreatic duct orifice

50.2

12.8

JJ3AT

NOMESCO Finland

Cytology of liver with ultrasound guidance

50.2

12.8

N07BC02

ATC

methadone; systemic

14.1

12.7

EB4VA, ,

NOMESCO Finland

0.3

12.7

997

K83.8

ICD-10 Finland

Other specified diseases of biliary tract

15.5

12.6

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

32.2

12.6

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

3.9

12.5

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

12.5

8010/3-C25.0

ICD-O-3

Carcinoma, NOS, of head of pancreas

+∞

12.5

8480/3-C25.9

ICD-O-3

Mucinous adenocarcinoma of pancreas, NOS

+∞

12.5

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

12.5

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

12.5

1571A

ICD-9 Finland

Malignant neoplasm of pancreas, Body of pancreas

+∞

12.5

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

12.5

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

12.5

8249/3-C25.1

ICD-O-3

Neuroendocrine tumor, grade 2 of body of pancreas

+∞

12.5

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

12.5

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

9.3

12.5

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

130.6

12.4

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.9

12.4

154

827

SPAT1110

SPAT

Measurement of pain intensity

4.4

12.4

N05AX08

ATC

risperidone; systemic

0.4

12.4

1825

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

0.3

12.2

1003

L17

ICPC

Foot/toe symptom/complaint

0.7

12.1

376

5311

R03AC02

ATC

salbutamol; inhalant

0.7

12.1

863

10551

G04BD12

ATC

mirabegron; oral

0.5

12.0

112

2159

E13

ICD-10 Finland

Other specified diabetes mellitus

10.1

12.0

DFF00

NOMESCO Finland

Pure tone audiometry

0.5

12.0

1776

WZC00, ,

SPAT

0.4

11.9

1414

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

0.7

11.8

464

6263

B01AC04

ATC

clopidogrel; oral

0.6

11.7

278

4157

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

0.3

11.7

1190

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

0.5

11.7

108

2089

R93.2

ICD-10 Finland

Abnormal findings on diagnostic imaging of liver and biliary tract

4.5

11.7

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

65.2

11.6

D19

ICPC

Teeth/gum symptom/complaint

0.6

11.6

259

3926

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.0

11.5

123

627

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

11.5

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

+∞

11.5

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

11.5

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

11.5

C80.92

ICD-10 Finland

Malignant tumor without specified localization adenocarcinoma

+∞

11.5

JJB10

NOMESCO Finland

Atypcal resection of liver

+∞

11.5

L02BX02

ATC

degarelix; parenteral

+∞

11.5

L01BC04

ATC

carmofur; oral

+∞

11.5

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

+∞

11.5

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

11.5

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

11.5

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.6

11.4

104

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

13.7

11.4

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

120.5

11.4

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

120.5

11.4

C76.2

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Abdomen

120.5

11.4

Z2446

NOMESCO Finland

Social worker

2.0

11.3

131

687

207

Kela drug reimbursment

Chronic arrhythmias

0.6

11.3

262

3941

GD1AD

NOMESCO Finland

Thorax CT examination

2.0

11.2

124

640

SDA04

NOMESCO Finland

Demanding periodontal treatment

0.6

11.2

246

3748

N06DA03

ATC

rivastigmine; oral, transdermal

0.3

11.2

1093

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

0.7

11.2

556

7220

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

11.2

385

2701

WZC30, ,

SPAT

0.2

11.1

828

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.7

11.1

321

4608

WX704

NOMESCO Finland

Intubation

1.8

11.1

157

880

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.6

11.0

258

3875

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.7

11.0

451

6060

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

4.3

11.0

ZYC01, ,

SPAT

0.4

11.0

1154

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

43.5

10.9

ZXF10

NOMESCO Finland

Interruption caused by technical failure of equipment

43.5

10.9

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.6

10.9

243

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

0.7

10.8

776

9535

OAB44, ,

SPAT

0.3

10.8

939

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

0.5

10.8

1723

B01AF02

ATC

apixaban; oral

0.6

10.8

166

2760

K75.0

ICD-10 Finland

Abscess of liver

10.6

10.8

WX882

NOMESCO Finland

High dependency care

2.4

10.7

317

I50.0

ICD-10 Finland

Congestive heart failure

0.5

10.7

113

2098

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

0.6

10.6

178

2898

A21

ICPC

Risk factor for malignancy

60.2

10.6

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

60.2

10.6

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.0

10.6

117

604

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

4.1

10.6

SPAT1269

SPAT

Other puncture and/or drainage

5.3

10.6

AA1AD

NOMESCO Finland

CT of head and brain

0.7

10.6

461

6131

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

0.4

10.5

1441

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

0.5

10.5

110

2045

Z96.1

ICD-10 Finland

Presence of intraocular lens

0.6

10.5

220

3389

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

0.7

10.5

651

8178

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

110.4

10.4

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

110.4

10.4

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

110.4

10.4

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

10.4

L01EB02

ATC

erlotinib; oral

+∞

10.4

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

10.4

9680/3-C25.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of pancreas, NOS

+∞

10.4

WD215

NOMESCO Finland

Multiple therapy of methastized malignancy with hormones

+∞

10.4

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

10.4

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

10.4

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.7

10.4

196

WPA44

NOMESCO Finland

Nursing home for palliative care

32.6

10.3

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

32.6

10.3

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.2

10.3

413

2390A

ICD-9 Finland

Neoplasm of unspecified nature, Digestive system

8.2

10.3

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

4.9

10.3

SFA20

NOMESCO Finland

Two-surface restoration

0.8

10.2

806

9790

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

0.7

10.2

414

5582

M70.6

ICD-10 Finland

Trochanteric bursitis

0.5

10.2

123

2191

ZXD05

NOMESCO Finland

Urgent procedure

1.3

10.1

710

5632

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

0.4

10.1

1224

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

0.6

10.1

132

2296

D82

ICPC

Teeth/gum disease

0.7

10.1

394

5347

SFA30

NOMESCO Finland

Three-surface restoration

0.7

10.0

561

7173

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

10.1

10.0

H25.8

ICD-10 Finland

Other senile cataract

0.6

10.0

165

2697

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

3.3

10.0

114

EBA00

NOMESCO Finland

Extraction of tooth

0.7

10.0

461

6081

H81

ICPC

Excessive ear wax

0.6

9.9

240

3584

ZX050

NOMESCO Finland

Stereotactic radiotherapy

20.1

9.8

M54.5

ICD-10 Finland

Low back pain

0.7

9.7

459

6040

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

0.5

9.7

1743

L12

ICPC

Hand/finger symptom/complaint

0.6

9.6

142

2393

X76

ICPC

Malignant neoplasm breast female

55.2

9.6

WX290

NOMESCO Finland

Other blockage of nerve

0.7

9.6

484

6304

F51.0

ICD-10 Finland

Nonorganic insomnia

0.5

9.6

1775

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.3

9.6

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

5.0

9.6

BBA70

NOMESCO Finland

Implantation or transplantation of parathyroid gland

15.1

9.5

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

0.4

9.5

993

SDA01

NOMESCO Finland

Periodontal treatment, very brief

0.7

9.5

271

3910

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

3.2

9.5

118

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

3.7

9.4

I50.1

ICD-10 Finland

Left ventricular failure

0.4

9.4

1230

JDA12

NOMESCO Finland

Endoscopic insertion of gastric stent

100.4

9.4

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

100.4

9.4

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

100.4

9.4

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

100.4

9.4

D44.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Endocrine gland, unspecified

100.4

9.4

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

30.1

9.4

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

9.4

6706

FHL

Pancreatic homeectomy (eg Whipple)

+∞

9.4

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

9.4

OAA41

NOMESCO Finland

Health check based on individual needs

+∞

9.4

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

9.4

C24.02

ICD-10 Finland

Common bile duct

+∞

9.4

JN4SR

NOMESCO Finland

Very extensive PET-CT of receptors in whole body

+∞

9.4

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

+∞

9.4

8249/3-C25.0

ICD-O-3

Neuroendocrine tumor, grade 2 of head of pancreas

+∞

9.4

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

+∞

9.4

8140/3-C24.1

ICD-O-3

Adenocarcinoma, NOS, of ampulla of Vater

+∞

9.4

9061/3-C62.9

ICD-O-3

Seminoma, NOS, of testis, NOS

+∞

9.4

XW2BT

NOMESCO Finland

Other cytological test with X-ray guidance

+∞

9.4

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

+∞

9.4

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

9.4

1572A

ICD-9 Finland

Malignant neoplasm of pancreas, Tail of pancreas

+∞

9.4

Z3226

NOMESCO Finland

Physiotherapist

1.4

9.4

402

2938

I10

ICD-10 Finland

Essential (primary) hypertension

0.8

9.3

1411

15832

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

8.0

9.3

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

3.7

9.3

L30.9

ICD-10 Finland

Dermatitis, unspecified

0.6

9.3

195

3006

R06AX27

ATC

desloratadine; oral

0.7

9.2

251

3661

H02

ICPC

Hearing complaint

0.6

9.2

179

2814

RD210, ,

NOMESCO Finland

3.1

9.2

120

OAA80, ,

SPAT

0.2

9.2

424

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.9

9.2

114

614

TDA90, ,

SPAT

0.3

9.1

825

R96

ICPC

Asthma

0.5

9.1

1534

L02AE03

ATC

goserelin; implant

11.5

9.1

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

3.2

9.0

111

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

9.0

210

1351

UJD02

NOMESCO Finland

Gastroscopy

1.8

9.0

128

720

SPAT1111

SPAT

Planning of analgesia

3.1

9.0

122

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

0.6

8.9

124

2124

D01

ICPC

Abdominal pain/cramps general

1.6

8.9

212

1370

TKE00

NOMESCO Finland

Needle biopsy of prostate

2.2

8.9

351

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.5

8.9

219

K03.64

ICD-10 Finland

Dental calculus supragingival

0.7

8.8

289

4066

F03

ICD-10 Finland

Unspecified dementia

0.4

8.8

1209

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

10.7

8.8

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

2.7

8.8

179

R05

ICD-10 Finland

Cough

0.7

8.7

248

3587

WPA13, ,

SPAT

50.1

8.7

K72.0

ICD-10 Finland

Acute and subacute hepatic failure

6.6

8.6

K92.0

ICD-10 Finland

Haematemesis

2.1

8.6

362

I21.9

ICD-10 Finland

Acute myocardial infarction, unspecified

0.2

8.6

547

R74

ICPC

Upper respiratory infection acute

0.7

8.6

245

3543

WX725

NOMESCO Finland

Noninvasive ventilation

1.9

8.6

107

577

H26.4

ICD-10 Finland

After-cataract

0.6

8.6

132

2199

N03AX16

ATC

[U] pregabalin

1.4

8.6

512

3952

D13.9

ICD-10 Finland

Benign neoplasm: Ill-defined sites within the digestive system

16.3

8.5

G04CA52

ATC

tamsulosin and dutasteride; systemic

0.6

8.5

153

2448

BCA30

NOMESCO Finland

Unilateral adrenalectomy

90.3

8.4

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

90.3

8.4

OAB42, ,

SPAT

0.5

8.4

1468

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.0

8.4

407

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

8.3

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

8.3

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

+∞

8.3

PHH32

NOMESCO Finland

Plastic repair of superior mesenteric or portal vein

+∞

8.3

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

8.3

8000/3-C25.8

ICD-O-3

Neoplasm, malignant of overlapping lesion of pancreas

+∞

8.3

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

8.3

1BC05, ,

NOMESCO Finland

+∞

8.3

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

8.3

FM1FN

NOMESCO Finland

Heart function isotope examination

+∞

8.3

JN7SN

NOMESCO Finland

Somatostatin receptor SPECT

+∞

8.3

L02BX03

ATC

abiraterone; oral

+∞

8.3

8720/3-C44.6

ICD-O-3

Malignant melanoma, NOS, of skin of upper limb and shoulder

+∞

8.3

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

8.3

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

+∞

8.3

M54.4

ICD-10 Finland

Lumbago with sciatica

0.6

8.3

168

2618

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

0.6

8.3

129

2141

XX9CW

NOMESCO Finland

Submitting image material and/or investigation material to patient

4.1

8.3

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

2.7

8.3

156

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

2.8

8.2

145

A97

ICPC

No disease

0.6

8.2

194

2918

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

0.5

8.2

1700

OAB43, ,

SPAT

0.5

8.2

1507

G47.3

ICD-10 Finland

Sleep apnoea

0.7

8.2

271

3806

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

0.3

8.2

823

R05

ICPC

Cough

0.7

8.1

283

3940

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

0.6

8.1

184

2793

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

0.5

8.1

1186

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

4.8

8.1

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

33.4

8.1

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

8.1

XX9TB

NOMESCO Finland

Complementary X-ray examination with contrast

17.2

8.1

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

22.1

8.0

GD1AT

NOMESCO Finland

Biopsy of the lung with ultrasound guidance

22.1

8.0

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

0.7

8.0

302

4144

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

6.3

8.0

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

6.3

8.0

L01

ICPC

Neck symptom/complaint

0.6

8.0

135

2196

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

3.9

8.0

N05BA04

ATC

oxazepam; oral

1.3

7.9

602

4809

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

4.0

7.9

I48.2

ICD-10 Finland

Chronic atrial fibrillation

0.4

7.8

806

R10.0

ICD-10 Finland

Acute abdomen

2.1

7.8

336

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

7.8

768

6350

JJA20

NOMESCO Finland

Open biopsy of liver

10.8

7.8

JCF12

NOMESCO Finland

Endoscopic insertion of prosthetic tube into oesphagus

10.8

7.8

A10AC01

ATC

insulin (human); parenteral

1.5

7.8

228

1545

SCA01

NOMESCO Finland

Preventive oral health care, short

0.7

7.8

275

3818

JFB00

NOMESCO Finland

Partial resection of small intestine

2.8

7.7

133

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

7.7

177

1134

Z3231

NOMESCO Finland

Registered nurse

1.3

7.7

587

4688

M01AH05

ATC

etoricoxib; oral

0.8

7.7

980

11333

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

45.1

7.7

SPAT1122

SPAT

Ascites puncture

45.1

7.7

S77

ICPC

Malignant neoplasm of skin

15.1

7.7

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.0

7.7

434

C01DA14

ATC

isosorbide mononitrate; oral

0.7

7.7

369

4861

I25.2

ICD-10 Finland

Old myocardial infarction

0.6

7.6

109

1850

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

25.1

7.6

WPA41

NOMESCO Finland

Psychosocial conversational support in palliative care

25.1

7.6

N02BF01

ATC

gabapentin; oral

0.5

7.6

1114

R5140

NOMESCO Finland

Monitoring the use of the aid

0.6

7.5

103

1772

J45.9

ICD-10 Finland

Asthma, unspecified

0.7

7.5

235

3342

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

0.6

7.5

101

1743

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

0.2

7.5

511

WGA11

NOMESCO Finland

Planning of pain management

7.1

7.5

XJA00

NOMESCO Finland

Intraoperative abdominal ultrasonography

80.3

7.4

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

80.3

7.4

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

80.3

7.4

KFC10

NOMESCO Finland

Bilateral orchiectomy

80.3

7.4

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

80.3

7.4

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

80.3

7.4

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.9

7.4

433

RD160, ,

NOMESCO Finland

13.4

7.4

JK1AT

NOMESCO Finland

Cathetrisation of bile cyst with radiological guidance

13.4

7.4

D02

ICPC

Abdominal pain epigastric

1.7

7.3

117

682

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

7.3

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

7.3

V03AH01

ATC

diazoxide; systemic

+∞

7.3

18699

ICD-8 Finland

Malignant neoplasm of testis

+∞

7.3

WGA10

NOMESCO Finland

Measurement of pain intensity

+∞

7.3

C65

ICD-10 Finland

Malignant neoplasm of renal pelvis

+∞

7.3

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

7.3

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

7.3

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

+∞

7.3

C79.7

ICD-10 Finland

Secondary malignant neoplasm of adrenal gland

+∞

7.3

Z515, C250,

ICD-10 Finland

+∞

7.3

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

7.3

C67.0

ICD-10 Finland

Malignant neoplasm: Trigone of bladder

+∞

7.3

C85.0

ICD-10 Finland

Lymphosarcoma

+∞

7.3

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

7.3

JLA20

NOMESCO Finland

Needle biopsy of pancreas

+∞

7.3

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

+∞

7.3

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

7.3

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

7.3

PC2SC

NOMESCO Finland

Liver angiography with X-ray

+∞

7.3

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

+∞

7.3

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

0.6

7.2

113

1876

DFF15

NOMESCO Finland

Speech audiometry

0.4

7.2

861

JN1CM

NOMESCO Finland

Upper part of abdomen extensive MRI examination with 3 Tesla magnet

15.8

7.2

HA1RA, ,

SPAT

0.2

7.2

345

NF1AA, ,

SPAT

0.2

7.1

302

J01CA04

ATC

amoxicillin; systemic

0.8

7.1

1560

17062

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.1

7.1

309

KAD00

NOMESCO Finland

Partial nephrectomy

12.0

7.1

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

12.0

7.1

NG1AA, ,

SPAT

0.3

7.1

540

KMAK, ,

NOMESCO Finland

0.8

7.0

716

8525

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

0.7

7.0

338

4457

R42

ICD-10 Finland

Dizziness and giddiness

0.7

7.0

371

4822

L90

ICPC

Osteoarthrosis of knee

0.5

6.9

1106

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

6.3

6.9

JFB30

NOMESCO Finland

Right hemicolectomy

4.0

6.9

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

0.7

6.9

376

4866

P06

ICPC

Sleep disturbance

0.5

6.9

1451

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

6.9

1040

9024

ZY010

NOMESCO Finland

Hospital outpatient

2.0

6.8

341

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

4.1

6.8

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

2.4

6.8

197

H25.0

ICD-10 Finland

Senile incipient cataract

0.5

6.8

1268

JX1XB

NOMESCO Finland

Other X-ray examination of alimentary tract with contrast

9.3

6.8

Z53.8

ICD-10 Finland

Procedure not carried out for other reasons

6.1

6.8

TQW20

NOMESCO Finland

Tatoe

40.1

6.8

6672

FHL

Cholecocenterostomy

40.1

6.8

TKE10

NOMESCO Finland

Puncture of prostate

40.1

6.8

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

0.5

6.7

1393

G04CB02

ATC

dutasteride; oral

0.6

6.7

107

1768

Z01.1

ICD-10 Finland

Examination of ears and hearing

0.7

6.7

179

2629

N05AH04

ATC

quetiapine; oral

0.7

6.7

176

2592

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

0.6

6.7

158

2378

H29

ICPC

Ear symptom/complaint other

0.6

6.7

118

1898

C09CA06

ATC

candesartan; oral

0.7

6.7

320

4227

WPA43, ,

SPAT

22.6

6.7

Z01.7

ICD-10 Finland

Laboratory examination

0.6

6.7

147

2245

ZXF99

NOMESCO Finland

Other r3eason to interrupt procedure

6.4

6.6

N40

ICD-10 Finland

Hyperplasia of prostate

0.8

6.6

450

5648

R06.0

ICD-10 Finland

Dyspnoea

0.8

6.6

443

5568

D48.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Retroperitoneum

12.3

6.6

K02.0

ICD-10 Finland

Caries limited to enamel

0.6

6.6

110

1792

H13

ICPC

Plugged feeling ear

0.7

6.6

293

3915

G03HA01

ATC

cyproterone; systemic

10.0

6.5

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.5

6.5

152

E87.6

ICD-10 Finland

Hypokalaemia

1.9

6.5

453

FP1B5, ,

SPAT

0.1

6.5

266

ZXH06, ,

SPAT

0.3

6.5

635

K65.0

ICD-10 Finland

Acute peritonitis

2.8

6.5

112

GD1AA, ,

SPAT

0.5

6.5

1065

M48.0

ICD-10 Finland

Spinal stenosis

0.7

6.4

180

2617

U07.2

ICD-10 Finland

COVID-19, virus not identified

0.5

6.4

1361

OAB48, ,

SPAT

0.4

6.4

777

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

70.0

6.4

JDH32

NOMESCO Finland

Endoscopic dilatation of duodenum

70.0

6.4

M05BA02

ATC

clodronic acid; systemic

70.0

6.4

Z51.0

ICD-10 Finland

Radiotherapy session

70.0

6.4

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

70.0

6.4

K26.0

ICD-10 Finland

Duodenal ulcer, acute with haemorrhage

2.7

6.4

124

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.4

6.4

252

1813

I48

ICD-10 Finland

Atrial fibrillation and flutter

0.8

6.4

509

6256

H04.10

ICD-10 Finland

Dry eye syndrome

0.6

6.3

1580

N02AJ06

ATC

codeine and paracetamol; systemic

0.8

6.3

606

7287

M53.0

ICD-10 Finland

Cervicocranial syndrome

0.5

6.3

1057

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

0.8

6.3

406

5138

201

Kela drug reimbursment

Chronic cardiac insufficiency

0.6

6.3

1415

BBA40

NOMESCO Finland

Subtotal parathyroidectomy

6.0

6.3

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

6.0

6.3

ZXE90

NOMESCO Finland

More than 22 hours

3.2

6.3

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

9.3

6.3

K81.9

ICD-10 Finland

Cholecystitis, unspecified

2.5

6.3

149

ZJX00

NOMESCO Finland

Double balloon technique in gastroenterological endoscopy

18.1

6.3

BBA50

NOMESCO Finland

Total parathyroidectomy

18.1

6.3

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

6.3

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

+∞

6.3

D63.0

ICD-10 Finland

Anaemia in neoplastic disease

+∞

6.3

1733A

ICD-9 Finland

Other malignant neoplasm of skin, Skin of other and unspecified parts of face[KASVOJEN IHON SYÖPÄ,CA BASOCELLULARE]

+∞

6.3

8020/3-C25.9

ICD-O-3

Carcinoma, undifferentiated, NOS, of pancreas, NOS

+∞

6.3

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

+∞

6.3

L02BB04

ATC

enzalutamide; oral

+∞

6.3

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

6.3

YJ3VG

NOMESCO Finland

MRI examination of abdomen with high intesity magnet for dose design of radiotherapy

+∞

6.3

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

6.3

HAC25

NOMESCO Finland

Radical mastectomy

+∞

6.3

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

6.3

WPA15, ,

SPAT

+∞

6.3

8090/3-C44.2

ICD-O-3

Basal cell carcinoma, NOS, of external ear

+∞

6.3

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

+∞

6.3

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

6.3

C76.8

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Overlapping lesion of other and ill-defined sites

+∞

6.3

C02.11

ICD-10 Finland

Malignant neoplasm of border of tongue

+∞

6.3

8151/3-C25.9

ICD-O-3

Insulinoma, NOS, of pancreas, NOS

+∞

6.3

L02AE04

ATC

triptorelin; parenteral

+∞

6.3

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

6.3

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

6.3

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

6.3

C78.4

ICD-10 Finland

Secondary malignant neoplasm of small intestine

+∞

6.3

C82.1

ICD-10 Finland

Follicular lymphoma grade II

+∞

6.3

8246/3-C25.2

ICD-O-3

Neuroendocrine carcinoma, NOS, of tail of pancreas

+∞

6.3

KCC10

NOMESCO Finland

Cystoprostatectomy

+∞

6.3

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

6.3

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

+∞

6.3

C26.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of digestive system

+∞

6.3

C62.11

ICD-10 Finland

Malignant tumor of the descending testicle, seminoma

+∞

6.3

C24.0

ICD-10 Finland

Malignant neoplasm: Extrahepatic bile duct

+∞

6.3

8480/3-C25.0

ICD-O-3

Mucinous adenocarcinoma of head of pancreas

+∞

6.3

8550/3-C25.9

ICD-O-3

Acinar cell carcinoma of pancreas, NOS

+∞

6.3

C77.9

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph node, unspecified

+∞

6.3

NH3AA, ,

SPAT

0.2

6.2

297

B01AF01

ATC

rivaroxaban; oral

0.7

6.2

180

2600

K52.1

ICD-10 Finland

Toxic gastroenteritis and colitis

26.7

6.2

JN5KR

NOMESCO Finland

Very extensive PET-CT of upper body metabolism (eyebrows to thighs)

26.7

6.2

JLB42

NOMESCO Finland

Transduodenal endoscopic dilatation of pancreatic duct

26.7

6.2

OAA67, ,

SPAT

0.4

6.2

876

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.5

6.2

902

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

0.2

6.2

278

XCW99

NOMESCO Finland

Other investigative procedure of eye

0.6

6.1

130

2004

XF400

NOMESCO Finland

ECG with 12 standard connections

1.3

6.1

416

3264

C09CA01

ATC

losartan; oral

0.8

6.1

444

5530

F06.7

ICD-10 Finland

Mild cognitive disorder

0.3

6.1

556

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

0.4

6.1

615

XX9TE

NOMESCO Finland

Compementary ultrasound examination

4.1

6.1

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

1.9

6.1

370

XX4BW, ,

NOMESCO Finland

12.5

6.1

E13.7

ICD-10 Finland

Other specified diabetes mellitus, with multiple complications

8.6

6.0

ZXE70

NOMESCO Finland

Moren than 15 and less than 18 hours

6.7

6.0

N06DA04

ATC

galantamine; oral

0.3

6.0

537

C07AB07

ATC

bisoprolol; oral

0.8

6.0

1124

12597

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

724

216

44.86

307.65

6.1

1.8

6113.37

23.59

u/ml

5.95

675

196

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

316

39.90

307.65

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

957

399

35.92

307.65

6.7

1.8

15963.98

28.20

u/ml

1.78

871

311

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

502

69.29

307.65

4.5

1.7

18.06

4.28

nmol/l

0.69

496

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

890

1981

6.12

307.65

5.2

2.1

42.78

7.91

umol/l

40.92

833

1696

(3000570) Elastase.pancreatic [Mass/mass] in Stool

791

559

19.33

307.65

1.6

1.4

154.62

283.83

ug/g

29.68

470

341

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

839

1574

7.18

307.65

3.4

1.9

0.19

0.20

g/l

3.03

793

1407

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1538

1097

29.89

307.65

5.8

1.3

71.73

2.76

ug/l

2.91

1443

819

(4035726) Immunohistochemistry procedure

484

496

11.59

307.65

1.3

1.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1554

6533

4.10

296.70

5.6

2.3

97.57

60.80

u/l

1.44

1492

5957

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

666

1690

4.86

247.60

7.1

2.1

111.12

38.83

u/l

0.80

587

1404

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1879

10066

3.63

227.33

22.5

3.7

27.11

12.25

umol/l

30.06

1827

9351

(40768441) Liver Pathology biopsy report

152

25.06

214.60

1.0

1.3

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1674

9004

3.14

187.58

11.1

3.7

30.96

35.12

g/l

127.67

1623

8170

(3023368) Bacteria identified in Blood by Culture

1300

6093

3.12

185.65

6.4

3.9

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

166

349.27

165.98

2.8

4.8

820.02

926.80

u/l

—

150

(3022217) INR in Platelet poor plasma by Coagulation assay

1757

10940

2.63

129.17

13.5

19.8

1.32

1.40

inr

0.98

467

3007

(3033658) Prothrombin time (PT) actual/Normal

995

4778

2.68

125.04

6.7

3.5

77.28

83.56

13.31

977

4638

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

129

150.18

122.29

4.0

2.6

97.24

89.57

pmol/l

—

107

(3044640) Blood type and Crossmatch panel - Blood

1119

5810

2.54

118.26

3.3

2.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1125

5881

2.53

116.88

6.3

2.6

67.18

38.27

u/l

9.80

1085

5495

(3010370) Gastrin [Moles/volume] in Serum or Plasma

34.52

116.65

2.9

1.3

35.68

24.83

pmol/l

0.66

(3012095) Magnesium [Moles/volume] in Serum or Plasma

717

3093

2.77

109.26

3.3

2.4

0.81

0.82

mmol/l

1.00

685

2816

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1419

8690

2.28

97.96

3.5

2.4

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1635

10815

2.23

90.92

23.7

5.9

4.59

4.43

e9/l

1.28

1468

9233

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

806

4036

2.40

87.33

8.4

2.2

2.50

2.45

mmol/l

17.57

769

3427

(3042936) Bacteria identified in Isolate by Culture

633

2854

2.57

85.97

2.1

2.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

844

4445

2.29

80.27

3.0

2.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1131

6805

2.11

75.99

9.0

2.1

2.32

2.35

mmol/l

12.06

1067

5634

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1551

20012

0.50

69.24

3.8

4.8

1.35

1.43

mmol/l

10.76

1339

18063

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

131

239

5.70

68.78

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1577

20223

0.50

68.77

3.8

4.8

4.34

4.46

mmol/l

4.55

1371

18395

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1646

20788

0.49

67.92

4.2

5.5

2.50

2.59

mmol/l

3.35

1425

18812

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

376

1494

2.75

64.50

1.6

—

(3023183) Ammonium ion [Moles/volume] in Plasma

172

436

4.14

60.87

1.8

2.4

36.49

35.23

umol/l

0.17

154

388

(3002256) Pathology report gross observation

345

1362

2.75

59.72

1.5

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

265

913

3.10

58.77

2.3

1.7

1.89

1.75

ug/l

0.08

241

778

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

231

741

3.31

57.70

2.4

3.0

0.30

0.35

u/ml

1.66

120

443

(3023487) Leukocytes [#/volume] in Peritoneal fluid

11.57

56.98

1.5

2.4

8189.16

840.57

e6/l

0.57

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1529

19375

0.54

55.10

3.6

4.3

1.35

1.28

mmol/l

3.51

1314

17305

(3003694) ABO and Rh group [Type] in Blood

777

4568

1.97

51.51

1.4

1.3

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

536

2761

2.16

50.89

3.3

5.0

0.99

1.03

mmol/l

2.71

509

2504

(40758558) Short blood count panel - Blood

768

4544

1.95

49.68

18.7

4.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

156

433

3.76

48.54

1.6

1.4

0.65

0.82

nmol/l

2.51

143

353

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1374

9819

1.78

47.99

7.6

5.1

1.19

1.21

mmol/l

11.81

1304

8692

(3024980) IgG subclass 4 [Mass/volume] in Serum

114

256

4.60

47.11

1.4

1.7

0.75

0.92

g/l

0.60

200

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1511

18917

0.56

46.88

4.0

4.6

2.11

2.10

mu/l

0.03

1306

16892

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1478

10847

1.77

46.57

8.4

5.5

1.20

1.21

mmol/l

10.12

1244

9136

(3018677) aPTT in Platelet poor plasma by Coagulation assay

612

3414

2.01

46.51

2.1

1.9

30.33

30.06

0.42

601

3288

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1683

20424

0.56

46.07

4.8

5.1

6.78

6.10

mmol/l

36.64

1495

18244

(3013826) Glucose [Moles/volume] in Serum or Plasma

1673

12759

1.77

45.78

7.6

4.3

7.96

6.91

mmol/l

40.05

1615

11900

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

653

3756

1.96

45.31

2.0

1.8

—

(40768804) Tissue Pathology biopsy report

925

5991

1.81

44.11

2.6

1.6

—

(3033799) Differential panel - Peritoneal fluid

10.60

43.79

1.5

1.7

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

10.37

43.15

1.3

2.1

14725.48

51194.67

e6/l

0.38

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

267

5609

0.42

40.53

1.6

1.44

1.33

mmol/l

0.70

241

4642

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

222

4.54

40.06

1.4

1.2

1.17

1.46

nmol/l

1.69

195

(4281824) Cell count and differential, peritoneal fluid

6.76

39.96

1.3

1.1

—

(3014007) Fractional oxyhemoglobin in Arterial blood

304

1367

2.37

39.43

7.9

7.6

94.57

93.25

3.80

304

1360

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

148

461

3.33

38.58

1.6

1.5

197.55

25.99

u/ml

4.09

140

434

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

13.49

38.26

1.2

2.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

480

2625

2.00

37.82

1.8

—

(3018418) pH of Serum or Plasma

934

6307

1.72

37.15

5.6

3.2

7.40

0.25

209

1079

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

478

2631

1.98

36.90

1.9

1.7

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1919

15701

1.71

36.15

24.3

5.3

195.27

76.87

u/l

110.91

1871

14408

(3002173) Hemoglobin [Mass/volume] in Arterial blood

408

2140

2.06

35.97

8.5

6.6

114.65

121.65

g/l

10.68

397

2078

(3002582) Erythrocytes [#/volume] in Urine

938

6422

1.69

34.99

3.2

3.1

28.09

80.59

e6/l

3.77

739

4914

(3000963) Hemoglobin [Mass/volume] in Blood

1971

22448

0.59

33.23

50.8

21.2

119.66

134.99

g/l

306.52

1923

21923

(3007461) Platelets [#/volume] in Blood

1970

22436

0.59

33.14

50.5

21.1

255.53

240.59

e9/l

12.22

1903

21632

(3026361) Erythrocytes [#/volume] in Blood

1971

22442

0.59

33.07

50.5

21.1

4.04

4.45

e12/l

201.49

1895

21533

(3035941) MCH [Entitic mass]

1971

22441

0.59

33.04

50.3

21.0

30.16

30.47

12.52

1924

21913

(3024731) MCV [Entitic volume]

1971

22440

0.59

33.02

50.3

21.0

91.28

91.66

3.16

1925

21910

(3010813) Leukocytes [#/volume] in Blood

1971

22438

0.59

32.96

50.4

21.1

7.63

6.84

e9/l

32.57

1893

21530

(3009542) Hematocrit [Volume Fraction] of Blood

1971

22422

0.59

32.53

50.7

21.2

35.72

39.83

116.28

1782

20413

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1200

15327

0.62

32.46

3.5

3.8

15.07

15.04

pmol/l

0.14

1044

13627

(3044007) Cell count panel - Peritoneal fluid

9.18

32.14

1.2

2.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

284

1350

2.23

32.10

1.7

1.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

156

563

2.88

31.57

1.9

1.7

—

(3030467) Casts [#/volume] in Urine by Automated count

853

5856

1.66

30.63

3.1

3.0

0.72

0.49

e6/l

1.75

671

4461

(3016502) Oxygen saturation in Arterial blood

424

2378

1.92

30.55

8.2

6.3

96.53

94.90

6.14

411

2273

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1674

19714

0.62

30.44

7.7

6.6

45.57

41.05

mmol/mol

40.18

1539

17958

(3027923) C peptide [Moles/volume] in Serum or Plasma

121

5.22

30.24

1.3

0.94

1.15

nmol/l

1.13

(3026782) Osmolality of Urine

664

4347

1.69

28.23

3.0

2.8

541.08

542.07

mosm/kgh2o

0.04

597

3678

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

492

2963

1.80

28.11

2.0

2.6

19.28

22.22

4.14

419

2457

(3003396) Base excess in Arterial blood by calculation

446

2617

1.84

27.73

8.0

6.1

1.14

1.27

mmol/l

0.32

381

2024

(3000991) Gas panel - Venous blood

334

1794

1.98

27.15

6.4

6.7

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

446

2635

1.82

27.07

8.0

6.1

5.05

kpa

0.04

430

2491

(3027801) Oxygen [Partial pressure] in Arterial blood

446

2635

1.82

27.07

8.0

6.1

13.66

11.37

kpa

14.43

431

2488

(3014111) Lactate [Moles/volume] in Serum or Plasma

351

1926

1.94

26.80

5.8

5.7

1.53

1.46

mmol/l

0.56

345

1870

(3004789) Transferrin [Mass/volume] in Serum or Plasma

510

3155

1.75

26.43

2.0

2.5

2.18

2.27

g/l

2.87

485

2877

(36304419) Bacteria [Presence] in Urine

805

5640

1.60

25.76

3.1

3.0

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

236

1136

2.18

25.72

10.1

8.5

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

276

3.41

25.47

6.0

6.2

12.01

12.31

mg/l

0.24

251

(3022948) Iron [Moles/volume] in Serum or Plasma

539

3455

1.69

24.37

2.1

2.5

10.35

12.58

umol/l

11.14

520

3157

(3018095) Leukocytes [#/volume] in Urine

996

7418

1.53

23.96

3.6

3.5

73.86

116.62

e6/l

1.58

759

5281

(3021447) Carbon dioxide [Partial pressure] in Venous blood

386

2268

1.81

23.65

3.1

3.2

5.60

5.85

kpa

5.92

373

2182

(3002032) Base excess in Venous blood by calculation

383

2256

1.81

23.25

3.1

3.2

2.05

2.04

mmol/l

0.02

316

1890

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1653

19100

0.67

22.19

35.6

13.5

81.05

73.30

ml/min/173m2

42.14

1477

15355

(3012544) pH of Venous blood

391

2358

1.77

21.84

3.2

—

7.37

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1465

11967

1.47

21.64

5.2

3.0

232.68

50.78

u/l

58.25

1391

10798

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

111

419

2.72

20.67

2.2

2.1

233.57

193.09

4.00

101

399

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

303

3.04

20.66

1.1

23.60

74.10

iu/ml

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1961

21818

0.66

20.51

39.1

17.8

3.95

4.00

mmol/l

15.66

1912

21101

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1948

21686

0.67

20.20

27.2

9.3

42.35

25.07

u/l

61.70

1900

20577

(3020779) Urea [Moles/volume] in Serum or Plasma

336

1993

1.78

19.77

3.6

6.5

8.70

11.55

mmol/l

9.76

315

1867

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

498

3288

1.63

19.67

2.9

2.8

3.25

2.37

e6/l

0.88

270

1809

(3020891) Body temperature

200

1002

2.07

19.59

5.7

4.5

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1961

21767

0.67

19.52

39.2

17.7

137.71

139.74

mmol/l

131.09

1913

21089

(3008152) Bicarbonate [Moles/volume] in Arterial blood

278

1567

1.86

19.32

9.1

6.3

24.31

24.45

mmol/l

0.24

265

1487

(3024354) Oxygen [Partial pressure] in Venous blood

321

1892

1.79

19.28

2.9

2.8

4.46

4.48

kpa

0.03

309

1811

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

252

3.16

19.22

2.4

5.0

3479.83

586.97

iu/ml

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

217

1130

2.00

19.10

2.5

2.4

0.71

0.66

1.36

217

1123

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

252

1410

1.87

17.90

1.9

1.7

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

522

7358

0.64

17.89

1.9

2.2

151.02

225.87

u/l

2.91

477

6832

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

106

428

2.53

17.28

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

142

654

2.23

17.24

1.2

—

(3019069) Monocytes/100 leukocytes in Blood

1137

9149

1.41

16.59

5.2

5.7

8.59

8.87

1.41

1078

8391

(3004119) Hemoglobin [Mass/volume] in Venous blood

263

1529

1.79

16.47

3.2

3.0

119.97

129.69

g/l

10.41

256

1484

(40761511) CBC panel - Blood by Automated count

1891

20946

0.70

16.19

30.8

14.3

—

(3004809) Band form neutrophils/100 leukocytes in Blood

246

2.98

16.17

2.5

3.0

1.74

1.37

0.48

208

(3019060) Gas panel - Arterial blood

275

1634

1.76

15.98

6.7

4.3

—

(3006504) Eosinophils/100 leukocytes in Blood

1127

9098

1.40

15.94

5.0

5.4

2.37

2.99

17.50

1068

8337

(3002030) Lymphocytes/100 leukocytes in Blood

1151

9325

1.40

15.94

5.2

5.6

21.97

26.31

28.16

1093

8584

(40760892) CBC W Ordered Manual Differential panel - Blood

1124

9077

1.40

15.84

5.6

—

(3000850) Epithelial cells [#/volume] in Urine

622

4524

1.48

15.49

2.6

2.5

7.55

4.82

e6/l

3.26

574

4010

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

409

2.47

15.41

1.3

1.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

249

2.90

15.24

1.0

—

(1761868) Lipid panel - Serum or Plasma

414

5964

0.64

15.21

3.0

3.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

241

2.91

14.93

1.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

541

7353

0.67

14.89

3.9

3.8

21.14

24.43

5.86

250

3623

(3022096) Basophils/100 leukocytes in Blood

1089

8828

1.38

14.66

5.0

5.4

0.57

0.67

6.56

1030

8082

(3031040) Bacteria [#/volume] in Urine by Automated count

1610

13901

1.37

14.57

4.6

4.7

334.56

2956.26

e6/l

2.88

233

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

172

3061

0.53

14.38

1.1

1.2

9.50

16.50

u/ml

0.72

1121

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

4.96

14.04

3.1

2.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

303

2.62

13.82

1.3

1.4

—

(3018010) Neutrophils/100 leukocytes in Blood

1124

9225

1.36

13.75

5.0

5.4

61.87

58.48

13.24

1066

8488

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

501

3566

1.49

13.72

2.8

2.7

1.27

1.32

e6/l

0.10

272

2078

(3012501) Base excess in Blood by calculation

107

483

2.26

13.68

5.6

4.7

2.97

2.73

mmol/l

0.39

317

(3027273) Bicarbonate [Moles/volume] in Venous blood

218

1277

1.77

13.28

3.6

2.9

24.55

25.22

mmol/l

1.89

208

1227

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

191

3205

0.57

12.93

1.2

1.3

38.22

41.60

iu/ml

0.15

996

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

180

1008

1.84

12.73

7.8

4.3

1.67

1.63

0.23

167

940

(3036489) Thrombin time

126

627

2.06

12.61

2.0

1.8

23.19

21.19

2.50

118

560

(3039000) Anion gap in Blood

106

499

2.17

12.26

10.5

6.1

10.99

11.40

mmol/l

0.74

443

(3018572) Chloride [Moles/volume] in Blood

106

499

2.17

12.26

10.5

6.1

105.90

104.93

mmol/l

1.19

443

(3033705) Calcium.ionized [Moles/volume] in Venous blood

334

2.44

12.24

3.0

2.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

722

9079

0.72

12.13

4.1

3.9

2.65

2.13

ug/l

1.37

603

8070

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

272

1738

1.63

11.98

6.0

3.1

1.22

1.23

mmol/l

0.94

256

1465

(3010421) pH of Blood

114

559

2.08

11.88

5.5

4.5

7.42

0.63

107

509

(3006922) Hepatitis E virus Ab [Presence] in Serum

3.75

11.83

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

175

995

1.81

11.79

8.0

4.4

0.91

0.87

0.79

163

930

(4062490) Immunoglobulin typing, IgG

162

3.06

11.73

1.2

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

263

2.59

11.68

1.3

1.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

358

5064

0.66

11.58

2.9

2.7

0.78

0.73

ug/l

0.36

239

3517

(3017143) Hepatitis C virus Ab [Presence] in Serum

225

1389

1.67

11.34

1.3

1.5

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

162

3.00

11.11

1.2

1.4

0.45

0.39

g/l

0.37

117

(3028192) IgG subclass 2 [Mass/volume] in Serum

162

3.00

11.11

1.2

1.4

3.20

2.98

g/l

0.49

117

(3027135) IgG subclass 1 [Mass/volume] in Serum

162

3.00

11.11

1.2

1.4

6.47

7.00

g/l

0.42

118

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

131

3.24

11.09

1.1

1.2

10.50

9.54

mmol/l

0.43

120

(3035637) Corticotropin [Mass/volume] in Plasma

142

3.13

10.99

1.9

1.5

—

(3047181) Lactate [Moles/volume] in Blood

135

724

1.91

10.95

9.2

5.4

1.53

1.32

mmol/l

1.60

119

636

(3001604) Monocytes [#/volume] in Blood

1158

9773

1.32

10.93

4.9

5.2

0.64

0.62

e9/l

1.27

963

8323

(3028308) Erythrocytes [#/volume] in Pleural fluid

209

2.71

10.80

1.2

1.5

29934.63

70271.91

e6/l

0.68

127

(3006315) Basophils [#/volume] in Blood

1161

9815

1.31

10.78

4.9

5.2

0.04

e9/l

1.65

966

8365

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

233

1471

1.64

10.76

1.3

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

200

2.73

10.58

1.3

1.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

265

2.49

10.51

1.3

1.5

34.52

27.13

g/l

2.87

236

(3023199) Leukocytes [#/volume] in Pleural fluid

237

2.57

10.36

1.2

1.5

2645.47

1508.63

e6/l

0.68

175

(3002385) Erythrocyte distribution width [Ratio]

1529

17079

0.77

10.30

44.6

16.7

15.50

15.35

0.76

1507

16663

(3013707) Erythrocyte sedimentation rate by Westergren method

1365

15469

0.77

10.28

3.3

4.1

17.89

13.27

mm/h

16.19

1239

14134

(3017181) Myelocytes/100 leukocytes in Blood

239

1545

1.60

10.02

2.5

3.6

1.15

0.88

0.90

139

418

(3019198) Lymphocytes [#/volume] in Blood

1175

10017

1.30

10.01

5.1

5.2

1.63

1.80

e9/l

6.07

1007

8698

(3003338) MCHC [Mass/volume]

1483

16603

0.77

10.01

46.1

19.2

329.81

331.87

g/l

15.93

1456

16420

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

274

2.40

9.80

1.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

274

2.40

9.80

1.3

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

3.55

9.77

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

320

2221

1.50

9.74

5.4

3.4

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

317

2201

1.50

9.63

2.9

2.8

267.06

238.84

u/l

1.41

302

2019

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

+∞

9.38

1.1

0.0

—

(3026493) Urate [Moles/volume] in Serum or Plasma

440

5793

0.71

9.31

2.7

2.5

3751.59

6714.06

umol/l

0.74

353

4884

(3013115) Eosinophils [#/volume] in Blood

1181

10159

1.28

9.10

5.2

5.3

0.18

0.21

e9/l

5.19

998

8762

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

3.43

9.04

1.1

—

(40768797) Stomach Pathology biopsy report

383

2792

1.43

9.02

1.3

1.2

—

(3045788) Cell count panel - Pleural fluid

188

2.63

9.01

1.3

1.5

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

673

0.25

8.86

1.5

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

123

3.04

8.85

1.3

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

311

2.18

8.14

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1033

0.42

8.08

1.7

1.9

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

8.93

8.03

1.4

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

281

2.23

7.99

1.3

—

(40768800) Prostate Pathology biopsy report

120

2.94

7.96

1.3

1.1

—

(3026008) Bacteria identified in Urine by Culture

833

6950

1.28

7.92

3.0

3.4

—

(40761536) Microorganisms panel - Urine sediment

235

1598

1.51

7.88

3.8

4.0

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

329

2.12

7.85

3.9

3.5

59.94

58.73

0.32

329

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

158

2.62

7.53

1.3

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

201

2.41

7.43

1.3

1.4

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

201

2.41

7.43

1.3

1.4

—

(40768795) Lymph node Pathology biopsy report

6.46

7.40

1.3

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

197

2853

0.67

6.92

3.6

4.9

32.74

33.39

0.32

122

1846

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

846

9858

0.80

6.86

2.6

2.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

241

2.22

6.83

1.3

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

4.11

6.81

1.4

1.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

858

9973

0.80

6.78

2.1

91.48

93.38

pmol/l

0.54

536

5094

(3051651) Icteric interference index of Serum or Plasma

100

2.92

6.58

5.8

4.1

—

(3019977) pH of Arterial blood

128

2.68

6.57

3.6

2.3

7.42

7.43

0.15

(3025941) Bacteria identified in Stool by Culture

152

978

1.59

6.57

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

146

2.55

6.52

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

146

2.55

6.52

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

146

2.55

6.52

1.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

206

1423

1.48

6.43

2.4

3.5

0.76

0.71

0.11

114

368

(3021440) Promyelocytes/100 leukocytes in Blood

214

1490

1.47

6.42

2.5

3.7

0.16

0.08

1.08

116

362

(3007566) Smooth muscle Ab [Titer] in Serum

461

1.82

6.18

1.1

93.00

95.71

titre

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

252

2.12

6.15

1.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

146

949

1.57

6.06

1.9

1.7

—

(40768806) Pleura Pathology biopsy report

179

2.31

5.85

1.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

242

2.09

5.57

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

190

2.23

5.54

3.0

2.7

—

(1761482) Bacteria [#/volume] in Urine by Culture

109

680

1.63

5.40

4.9

4.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

519

1.72

5.39

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

519

1.72

5.39

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

3.03

5.37

1.1

1.0

—

(3025159) Blasts/100 leukocytes in Blood

199

1420

1.43

5.29

2.5

3.8

0.11

0.09

102

300

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

108

2.61

5.22

1.9

1.6

6833.69

1529.25

u/l

0.33

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

7.36

5.14

1.1

1.3

22.50

14.89

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

3.76

5.09

1.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

5.67

5.06

1.0

1.3

23.63

1987.55

u/l

—

(1616796) Gas panel - Central venous blood

487

1.70

4.93

3.4

3.9

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

100

2.61

4.89

1.3

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

118

2.47

4.87

2.4

1.7

16.05

15.67

nmol/l

0.10

102

(40767503) Oxygen content in Capillary blood by calculation

474

1.71

4.86

2.5

14.16

16.31

3.71

254

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

101

2.59

4.80

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

119

2.45

4.79

1.3

—

(3021788) Differential panel - Synovial fluid

430

0.32

4.77

1.9

1.4

—

(3012441) Differential panel - Pleural fluid

196

2.11

4.77

1.3

1.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

389

1.77

4.68

1.3

1.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

131

886

1.50

4.61

1.9

1.7

—

(3037522) Nuclear Ab [Titer] in Serum

181

2470

0.71

4.58

1.2

1.3

535.79

562.71

titre

0.05

560

(3012516) Albumin [Mass/volume] in Urine

639

7417

0.82

4.55

2.8

3.2

243.00

228.53

mg/l

0.04

413

4744

(3005719) IgG [Mass/volume] in Serum or Plasma

170

1214

1.43

4.53

1.8

2.1

9.81

10.93

g/l

3.84

141

1092

(3036481) Cortisol [Moles/volume] in Serum or Plasma

218

1636

1.36

4.35

2.5

1.8

432.83

366.28

nmol/l

3.46

202

1453

(3044889) 12 lead EKG panel

1383

14958

0.85

4.30

4.3

4.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

604

0.46

4.29

1.5

29333.95

14324.65

e6/l

0.41

437

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

106

698

1.54

4.25

2.3

2.9

—

(3004588) Protein electrophoresis panel - Serum or Plasma

114

1663

0.67

4.20

2.0

1.5

—

(3044290) Cell count panel - Cerebral spinal fluid

370

0.32

4.16

1.2

—

(1002224) Polysomnography panel

541

0.44

4.14

1.0

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

383

0.34

4.12

1.4

1.7

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.99

4.12

1.3

2.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

136

2.22

4.02

3.7

1.6

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

183

2.04

3.99

2.3

3.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

586

0.47

3.97

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

233

1.90

3.92

1.7

1.3

—

nmol/l

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

674

0.51

3.89

1.2

1.3

—

(3000492) Spirometry study

119

1689

0.69

3.81

1.4

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

129

1804

0.70

3.80

1.4

1.3

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

519

0.46

3.74

1.1

1.2

—

52.99

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

244

3091

0.77

3.74

14.2

7.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

118

818

1.46

3.74

1.2

1.3

—

(3008898) HLA-B27 [Presence]

430

0.41

3.63

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

233

1.86

3.60

1.7

1.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

277

1.78

3.59

1.1

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

265

0.34

3.55

1.0

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

764

8566

0.85

3.51

2.4

2.2

71.28

78.89

nmol/l

10.28

699

7400

(21494755) Public health laboratory ask at order entry panel

828

0.58

3.50

1.2

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

165

2.01

3.49

1.2

1.3

—

(3035880) pH of Pleural fluid

107

2.25

3.38

1.1

1.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

614

0.53

3.33

1.5

1.7

—

(40768793) Breast Pathology biopsy report

2.37

3.31

1.2

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

4.36

3.30

1.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

450

5235

0.83

3.15

1.7

1.8

1203.27

1162.64

nmol/l

0.43

364

3902

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

2.63

3.13

1.8

2.4

—

(3008295) Osmolality of Serum or Plasma

194

1.87

3.11

1.3

1.4

273.62

273.89

mosm/kgh2o

0.03

141

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

261

1.74

3.07

1.8

1.3

0.60

0.66

nmol/l

0.51

249

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

239

1.77

3.05

1.1

1.3

111.32

114.12

u/ml

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.44

3.04

1.1

1.2

—

(4200892) Spirometry reversibility

112

1540

0.72

3.04

1.2

1.4

—

(3044941) Cell count panel - Synovial fluid

394

0.45

2.97

1.3

1.4

—

(40768443) Skin Pathology biopsy report

803

0.62

2.96

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

653

0.58

2.94

2.8

3.2

0.75

0.85

nmol/l

1.55

493

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1958

20390

0.87

2.94

36.4

14.5

40.38

25.29

mg/l

58.64

1881

16124

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

135

2.01

2.90

1.0

—

(3016018) Differential panel - Cerebral spinal fluid

172

0.29

2.82

1.0

1.2

—

(3003181) Sodium [Moles/volume] in Urine

402

1.55

2.78

1.2

1.3

66.57

62.17

mmol/l

0.31

319

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

5.01

2.73

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

167

1.87

2.71

1.7

2.8

66.28

60.39

0.85

135

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

671

1.41

2.64

1.8

1.6

—

(3011648) Oxygen content in Venous blood

169

1.84

2.63

1.4

1.8

11.78

10.60

0.82

169

(3009508) Creatinine [Moles/volume] in Urine

677

7521

0.87

2.63

2.7

3.2

6.92

7.26

mmol/l

1.45

542

6232

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

648

5791

1.15

2.61

2.1

2.3

3.11

2.99

mg/l

0.62

570

4865

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.00

2.60

0.0

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

0.00

2.60

0.0

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.00

2.60

0.0

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.00

2.60

0.0

1.0

—

(3004451) EKG impression Narrative

127

1.98

2.60

1.1

1.3

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

0.00

2.60

0.0

1.1

—

14.56

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

0.00

2.60

0.0

1.0

—

2.48

—

(3024928) Oxygen saturation in Venous blood

474

1.49

2.59

2.2

2.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.31

2.58

1.1

1.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

869

0.66

2.55

2.0

1.4

3.06

2.98

g/l

0.24

748

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

261

1.66

2.54

1.8

1.3

0.16

0.43

nmol/l

—

(3045424) Erythrocytes [Presence] in Urine

329

0.45

2.53

1.9

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

420

1.51

2.52

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

780

0.65

2.49

2.1

1.5

1.22

0.44

g/l

1.36

658

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

180

1.79

2.47

1.2

1.3

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

4.38

2.47

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

203

1.73

2.44

1.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

931

0.68

2.44

1.9

1.4

7.45

7.52

g/l

0.11

808

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

931

0.68

2.44

1.9

1.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

714

7867

0.88

2.43

3.3

3.8

11.43

8.59

mg/mmol

0.67

444

4970

(3023410) Appearance of Cerebral spinal fluid

159

0.31

2.41

1.2

1.3

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

190

0.37

2.40

1.0

1.1

—

1.64

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

206

1672

1.25

2.40

5.2

2.3

68.71

61.50

ml/min/173m2

1.54

682

(3023420) DNA double strand Ab [Units/volume] in Serum

176

0.34

2.39

1.2

1.3

—

28.43

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

3.34

2.39

2.3

3.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

582

5194

1.15

2.38

3.7

3.5

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

186

1497

1.26

2.34

3.2

3.6

4.97

5.18

kpa

2.48

174

1401

(3019832) Treponema pallidum Ab [Presence] in Serum

597

0.61

2.31

1.3

1.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1128

0.72

2.30

1.8

2.1

11.88

14.69

nmol/l

2.52

973

(3024891) Influenza virus A+B Ag [Presence] in Specimen

454

1.46

2.30

1.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

930

0.69

2.29

1.9

1.4

3.70

3.77

g/l

0.13

808

(3052851) Hemolysis interference index of Serum or Plasma

607

1.40

2.25

4.8

3.6

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

353

0.51

2.25

1.1

1.2

—

42.23

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

286

0.45

2.25

1.6

1.5

66.00

65.13

—

183

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

747

0.66

2.21

2.1

1.4

36.78

37.35

g/l

0.26

626

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

718

7859

0.88

2.17

2.5

3.2

1230.35

1738.36

ng/l

3.70

632

6764

(3009343) pH of Capillary blood

182

1476

1.25

2.16

3.2

3.6

7.43

7.42

0.50

179

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

181

0.39

2.15

1.0

1.1

—

55.53

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

3.69

2.15

1.3

1.7

—

(3038026) Centromere Ab [Units/volume] in Serum

182

0.38

2.15

1.0

1.1

—

63.03

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.21

2.09

1.8

2.5

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

878

0.70

2.09

1.9

1.4

10.31

10.43

g/l

0.09

751

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

131

1.84

2.08

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

954

0.72

2.03

1.1

1.2

183.45

118.01

iu/ml

0.54

358

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

179

0.39

2.01

1.0

1.1

—

78.25

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.08

2.01

1.8

2.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

295

1.53

2.00

7.7

32.7

8.82

7.72

mmol/l

0.98

242

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

1.97

2.00

1.6

1.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

175

1428

1.24

1.99

3.2

3.5

2.16

1.92

mmol/l

0.26

119

1026

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.29

1.97

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

127

1.82

1.93

1.3

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

3.76

1.93

1.0

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

3.76

1.93

1.0

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

736

0.69

1.93

1.8

1.5

47.19

48.22

mg/l

0.05

599

(21494814) CD8 cells/100 lymphocytes in Specimen

2.73

1.93

2.2

2.7

—

(3042631) Mycobacterium sp identified in Specimen

274

1.54

1.92

2.1

2.9

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

793

0.70

1.91

1.2

1.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

734

0.69

1.90

1.8

1.5

29.62

34.51

mg/l

0.65

596

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

0.00

1.88

0.0

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

3.19

1.88

1.1

1.0

—

(3024263) Appearance of Synovial fluid

141

0.35

1.88

1.0

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.31

1.87

1.1

1.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1518

14495

1.10

1.85

4.0

4.4

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

196

0.46

1.84

1.0

1.4

—

200.40

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

4.17

1.82

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

4.17

1.82

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

4.17

1.82

1.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.13

1.82

2.6

2.9

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

549

0.65

1.81

1.6

22.05

5.48

iu/ml

0.33

125

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

714

0.69

1.80

1.8

1.5

1.36

3.20

ratio

—

(3052592) Norovirus Ag [Presence] in Stool

2.27

1.80

1.2

1.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.35

1.77

1.7

1.5

—

(3021960) Folate [Moles/volume] in Serum or Plasma

525

5789

0.89

1.76

1.6

20.33

20.14

nmol/l

0.11

492

4840

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

153

0.39

1.75

1.0

1.1

—

(3000330) Specific gravity of Urine by Test strip

155

1268

1.24

1.75

4.3

3.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

580

0.67

1.75

2.3

1.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

207

2440

0.84

1.72

2.2

2.4

3.03

7.48

ug/l

16.16

173

2089

(3001019) Free T4 and TSH panel - Serum or Plasma

481

0.64

1.71

1.4

1.8

—

(3021589) Normoblasts [#/volume] in Blood

924

8636

1.10

1.70

19.0

8.6

0.00

e9/l

0.68

726

6974

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

658

0.69

1.69

2.2

1.5

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

468

1.38

1.67

1.9

2.6

1.49

1.74

mg/l

1.92

403

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

163

0.43

1.66

1.0

1.1

—

6.67

—

(3028717) Thiamine [Mass/volume] in Blood

3.16

1.66

1.2

—

(3029937) Albumin [Presence] in Urine by Test strip

619

5676

1.12

1.64

3.8

4.2

0.00

estimate

0.50

203

1678

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

768

0.72

1.62

1.7

1.8

39.38

38.52

u/l

0.10

639

(3013139) Helicobacter pylori Ag [Presence] in Stool

160

1326

1.22

1.62

1.2

1.3

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

756

0.72

1.62

1.3

1.5

—

271.30

—

(3020393) Adenovirus Ag [Presence] in Stool

3.58

1.61

1.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

2.07

1.59

2.2

1.5

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

696

0.71

1.59

2.1

1.4

0.13

0.04

g/l

0.61

628

(3045414) Leukocytes [Presence] in Urine

922

0.75

1.57

2.1

1.9

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

207

0.48

1.54

1.0

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.04

1.54

1.6

2.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.04

1.54

1.6

2.7

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

182

0.49

1.50

1.0

1.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.12

1.44

1.1

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.12

1.44

1.1

1.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

125

1.69

1.43

1.3

16.94

10.89

u/l

0.51

109

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

516

4721

1.11

1.42

3.6

4.1

89.77

476.52

ng/l

7.33

421

4036

(3021901) Oxygen saturation in Capillary blood

465

1.34

1.42

3.5

2.6

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

202

1736

1.18

1.41

1.5

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

469

0.68

1.39

1.0

1.2

—

340.00

—

(3036603) Volume of Urine

111

1.72

1.39

1.3

1.4

1947.58

1946.69

0.00

104

(3047007) Chlamydophila sp Ab [Presence] in Serum

197

0.51

1.36

1.1

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

306

1.41

1.36

1.4

1.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

118

970

1.23

1.34

1.5

1.3

1.06

1.14

g/l

0.35

107

870

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

401

1.35

1.34

1.3

1.6

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

249

1.45

1.33

1.1

248.14

272.25

u/ml

0.24

154

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.97

1.32

1.1

1.3

—

(3017569) Oxygen content in Arterial blood

136

1.62

1.32

4.6

1.7

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

602

0.73

1.31

1.0

1.4

—

17.65

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

414

0.67

1.29

1.0

1.1

—

(4034850) Laboratory test

804

0.77

1.29

15.3

10.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

268

1.42

1.28

1.1

—

(3015183) Erythrocyte sedimentation rate

2.00

1.27

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

122

1.64

1.27

1.0

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

255

0.59

1.26

1.2

—

(21494434) Karyotype in Bone marrow

158

0.50

1.24

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

574

1.28

1.23

1.2

—

(3045142) Bone marrow Pathology biopsy report

139

1.59

1.23

1.3

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.04

1.22

1.3

1.7

2359.40

69.84

nmol/24h

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

143

0.49

1.20

1.0

1.2

2.96

2.03

mmol/l

—

134

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

649

0.75

1.20

2.2

1.4

0.04

0.00

g/l

0.49

582

(42529406) Shigella sp [Presence] in Stool by Culture

577

1.27

1.19

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.31

1.18

1.7

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

169

0.53

1.18

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

342

1.35

1.16

1.1

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

0.00

1.16

0.0

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

537

1.27

1.13

2.2

115.38

130.92

g/l

5.08

403

(3051611) Lipemic interference index of Serum or Plasma

208

1.45

1.12

5.7

3.5

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.34

1.12

1.1

1.3

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

127

1.58

1.11

1.5

1.3

11.95

15.10

u/l

1.80

120

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

127

1.58

1.11

2.7

2.5

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.38

1.09

1.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

969

9230

1.08

1.09

3.7

4.1

36.24

86.99

ng/l

1.64

794

7030

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

386

0.70

1.08

1.7

2.27

4.47

iu/l

2.70

122

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

636

0.77

1.07

2.2

1.4

0.00

g/l

-0.00

580

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

105

1.62

1.06

1.1

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

570

1.25

1.05

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

494

5314

0.91

1.05

1.7

461.29

29686835.21

pmol/l

3.93

395

4305

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

237

1.40

1.04

1.3

1.2

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.27

1.03

1.0

1.1

84.66

102.93

ng/l

—

(3020630) Protein [Mass/volume] in Serum or Plasma

166

1895

0.87

1.01

1.8

1.6

63.73

66.52

g/l

3.90

150

1671

(3019225) pH of Specimen

251

2255

1.12

1.00

3.9

3.7

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

173

1966

0.87

0.99

1.4

1.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

833

7917

1.07

0.99

4.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

1.84

0.98

1.2

1.4

15.23

15.06

pmol/l

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

240

1.38

0.98

1.3

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

241

1.37

0.96

1.3

1.2

—

(3009015) Lactate [Moles/volume] in Synovial fluid

0.00

0.95

0.0

1.2

—

7.63

—

(3032057) Clostridioides difficile [Presence] in Stool

1.78

0.94

1.5

1.8

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

235

1.37

0.91

1.3

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

541

0.77

0.90

1.8

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

237

1.35

0.87

1.3

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

217

0.64

0.87

1.1

1.2

—

51.56

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

183

2047

0.89

0.85

1.3

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

166

0.60

0.83

2.0

2.3

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

121

1.49

0.82

3.3

1.7

—

(3044927) Protein electrophoresis panel - Urine

307

0.71

0.81

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

294

0.71

0.80

1.1

1.5

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.79

0.0

3.7

—

(3035320) C reactive protein [Mass/volume] in Body fluid

139

1.44

0.79

4.5

2.6

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

0.00

0.79

0.0

1.1

—

2.82

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

0.79

0.0

1.7

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.78

0.0

1.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

406

0.76

0.77

1.3

—

(3016750) Collection duration of Urine

140

1.43

0.76

1.9

2.0

428.42

489.31

min

0.77

102

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

323

1.27

0.76

1.2

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

370

0.75

1.1

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

236

1.32

0.74

1.3

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

102

886

1.16

0.72

3.2

4.0

24.42

24.73

mmol/l

0.36

798

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

109

0.55

0.72

1.5

1.1

84.10

37.95

mg/l

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.92

0.70

3.2

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

284

1.27

0.68

1.9

1.3

—

(3051593) INR in Capillary blood by Coagulation assay

156

0.64

0.67

24.7

12.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

0.54

0.67

1.2

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

119

1.43

0.67

1.3

1.8

1.27

1.96

u/field

0.35

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.63

0.66

1.0

1.3

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

1.63

0.66

1.4

1.2

859.30

7.26

ug/l

—

(3000034) Microalbumin [Mass/volume] in Urine

232

1.30

0.66

2.3

3.1

21.87

26.11

mg/l

0.19

177

(3007853) Bacteria identified in Skin by Aerobe culture

262

2430

1.09

0.62

1.7

1.8

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

208

1.30

0.62

2.2

1.50

1.84

u/field

—

(3014891) Appearance of Pleural fluid

1.67

0.61

1.2

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

188

1719

1.10

0.61

1.4

1.7

1.66

1.57

0.51

150

1438

(3022313) Gas panel - Capillary blood

119

1061

1.13

0.61

3.2

3.7

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

137

0.66

0.60

1.0

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

137

0.66

0.60

1.0

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

137

0.66

0.60

1.0

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.48

0.60

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.48

0.60

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

140

0.64

0.60

1.0

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

140

0.64

0.60

1.0

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

140

0.64

0.60

1.0

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

141

0.64

0.60

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.00

0.60

0.0

1.9

—

17.54

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

232

0.73

0.59

3.4

3.7

—

(3019150) Specific gravity of Urine by Refractometry

458

4823

0.94

0.59

3.9

4.3

1.02

kg/l

0.62

745

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.54

0.59

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

0.00

0.59

0.0

1.1

—

4.49

—

(3048689) Calprotectin [Mass/mass] in Stool

183

1994

0.91

0.58

1.8

2.1

123.70

168.89

ug/g

0.99

147

1549

(3004716) Salmonella sp identified in Stool by Organism specific culture

746

1.14

0.56

1.4

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.57

0.56

1.2

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

0.57

0.56

1.2

2.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

1.45

0.55

1.0

1.2

—

(3028433) Virus identified in Specimen by Culture

1.48

0.53

1.1

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.54

0.53

1.7

1.0

—

(3017704) Immunofixation for Urine

134

0.67

0.51

1.1

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

165

1794

0.91

0.51

3.6

3.5

78.04

95.93

ng/l

2.24

138

1501

(36660697) Celiac disease serology panel - Serum

124

1366

0.90

0.51

1.1

1.2

—

(3004775) Volume in Urine collected for unspecified duration

215

1.26

0.51

2.1

2.3

724.88

623.46

0.42

131

(3013512) EKG study

657

6815

0.95

0.50

4.4

4.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

145

1.31

0.48

1.2

1.3

—

(3016879) Cocaine [Presence] in Urine

177

0.73

0.47

1.2

1.9

—

(3026389) Candida sp identified in Specimen by Organism specific culture

245

1.23

0.46

1.3

—

(3014271) Vancomycin [Susceptibility]

155

1.29

0.46

2.6

3.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

264

1.21

0.45

1.1

—

(3027945) Reticulocytes/100 erythrocytes in Blood

290

2742

1.06

0.45

2.2

2.1

1.94

1.75

1.34

272

2374

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

358

1.18

0.43

2.5

3.1

—

(3022621) pH of Urine by Test strip

161

1495

1.08

0.42

3.1

3.2

—

(3019174) dRVVT (LA screen)

0.00

0.41

0.0

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.41

0.0

1.2

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

0.82

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

205

0.78

0.40

1.1

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.40

0.0

1.0

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

0.84

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

390

1.16

0.39

1.2

—

(44813793) Dust mix specific IgE antibody measurement

101

0.69

0.39

1.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

105

0.67

0.39

1.7

2.0

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

0.00

0.39

0.0

1.1

—

25.67

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.39

0.38

1.0

1.1

—

(3002619) Bacteria identified in Specimen by Culture

1.39

0.38

1.2

—

(3036048) Francisella tularensis Ab [Titer] in Serum

1.39

0.38

1.0

1.2

—

(3000494) Fungus identified in Specimen by Culture

238

2254

1.06

0.37

1.7

1.4

—

(3006462) Nitrate [Presence] in Urine

113

0.71

0.37

2.1

3.6

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

115

0.69

0.37

1.0

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

0.66

0.35

2.4

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

222

0.81

0.34

1.0

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

1.36

0.34

1.0

—

(3022145) Colonoscopy Study observation

182

1930

0.94

0.34

1.3

—

(3037756) Immunofixation for Serum or Plasma

436

0.87

0.34

1.1

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

188

0.80

0.33

2.8

1.4

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.70

0.33

1.2

1.4

1.69

1.54

g/l

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

0.67

0.33

2.8

5.7

—

71.50

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

494

5099

0.96

0.33

3.2

3.9

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.67

0.32

1.0

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

304

1.15

0.31

1.3

1.2

—

(3020491) Glucose [Moles/volume] in Blood

174

1.21

0.31

2.0

2.7

7.24

6.90

mmol/l

0.27

116

(3000764) Benzodiazepines [Presence] in Urine

186

0.81

0.31

1.1

1.8

—

(3006653) Thiamine [Moles/volume] in Blood

0.72

0.30

1.1

1.2

139.86

142.68

nmol/l

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.32

0.30

3.6

1.6

0.85

1.41

ug/l

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.71

0.30

1.0

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.71

0.30

1.0

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

153

0.78

0.30

1.2

1.8

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

212

1.18

0.30

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

140

1.22

0.27

1.1

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

1.23

0.27

1.3

2.1

695.25

1024.49

u/ml

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.28

0.26

1.0

1.3

—

(3049717) Cytology report of Urine Cyto stain

762

1.08

0.25

2.9

1.8

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.72

0.24

1.0

1.1

—

(3009261) Glucose [Presence] in Urine by Test strip

1053

10377

1.02

0.23

3.8

3.9

0.00

0.01

estimate

1.08

220

1678

(3006270) Folate [Moles/volume] in Blood

227

1.15

0.23

1.2

468.86

342.88

nmol/l

1.51

188

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

115

1.22

0.23

1.3

1.5

16.89

6.73

u/l

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1.32

0.23

2.2

1.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1.19

0.21

1.2

1.4

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.21

0.0

1.5

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

0.21

0.0

1.7

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.21

0.0

1.7

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

575

0.92

0.21

2.2

2.7

—

(3028300) Cannabinoids [Presence] in Urine

188

0.85

0.21

1.2

1.8

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

0.21

0.0

2.9

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

201

1.15

0.21

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

101

0.79

0.21

2.3

2.2

—

(3021601) Nitrite [Presence] in Urine by Test strip

1038

10242

1.02

0.21

5.1

0.00

estimate

-0.00

233

1744

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.20

0.0

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

0.00

0.20

0.0

1.1

—

(3020618) Glucose [Moles/volume] in Synovial fluid

0.00

0.20

0.0

1.1

—

6.30

—

(3023419) Bacteria identified in Sputum by Culture

376

0.90

0.20

1.8

2.5

—

(3027008) Opiates [Presence] in Urine

187

0.85

0.20

1.2

1.8

—

(3011985) Renin [Units/volume] in Plasma

269

1.12

0.19

1.6

1.3

41.72

70.66

mu/l

0.87

243

(3017732) Neutrophils [#/volume] in Blood

135

1290

1.05

0.19

4.5

3.2

4.75

5.72

e9/l

0.93

111

942

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

367

3763

0.97

0.19

1.2

3.48

1.88

u/ml

0.46

948

(3051101) Glucose [Moles/volume] in Cord blood

1.13

0.18

4.2

6.8

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

929

0.95

0.18

2.3

2.9

4.09

4.40

pmol/l

1.72

791

(3027944) Amphetamines [Presence] in Urine

185

0.86

0.18

1.2

1.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

795

0.94

0.18

1.0

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

237

0.89

0.17

1.0

1.2

5.33

2.96

u/ml

—

(40761535) Cells panel - Urine sediment

195

2016

0.96

0.17

3.3

3.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

465

0.92

0.17

1.7

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.73

0.17

1.2

1.0

—

(21491868) Cryoglobulin [Mass/volume] in Serum

0.71

0.16

1.2

1.3

—

0.06

—

(21494890) Protein electrophoresis panel - 24 hour Urine

204

0.88

0.16

1.5

1.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

443

4353

1.02

0.14

1.7

3.44

1.36

mg/l

5.46

373

3369

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

179

1.12

0.14

1.0

1.1

11.70

2.51

u/ml

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.19

0.14

1.0

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.82

0.13

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

356

0.93

0.13

1.5

1.4

—

(3025130) Human papilloma virus identified in Specimen

106

0.85

0.13

1.4

1.8

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

670

0.95

0.11

2.4

2.2

109.97

104.88

ug/min

0.05

392

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

261

1.07

0.10

1.6

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.14

0.10

1.0

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.14

0.10

1.4

1.3

—

21.33

—

(3000012) Reticulocyte production index

320

1.06

0.09

1.6

1.7

—

(3034426) Prothrombin time (PT)

1.11

0.09

1.2

1.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.11

0.09

1.7

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

136

1.10

0.08

1.0

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

491

0.96

0.08

1.6

1.7

—

(3032773) Endomysium IgG Ab [Titer] in Serum

127

1.10

0.08

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

0.86

0.07

1.0

1.2

—

(3035350) Ketones [Presence] in Urine by Test strip

1034

10282

1.01

0.07

3.8

3.9

0.00

estimate

0.06

252

1922

(3047189) Immunofixation for 24 hour Urine

0.87

0.07

1.0

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

0.83

0.07

1.7

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

501

1.04

0.07

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

0.88

0.06

1.5

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

0.88

0.06

1.5

1.3

—

(3023520) Reticulocytes [#/volume] in Blood

204

2062

0.99

0.04

2.1

70.94

67.59

e9/l

0.44

160

1567

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

231

0.95

0.04

2.3

1.5

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

814

8111

1.01

0.03

2.4

2.8

246.07

139.84

ug/l

10.12

758

7331

(3051387) C reactive protein [Mass/volume] in Capillary blood

522

0.98

0.03

3.3

3.9

42.57

30.26

mg/l

1.28

354

(4146454) Self-monitoring of blood glucose

290

0.97

0.03

2.5

2.9

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

118

0.93

0.02

3.3

4.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

148

0.95

0.02

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

240

2414

0.99

0.02

2.7

3.3

197.71

240.27

ng/l

1.01

221

2224

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

228

0.96

0.02

1.0

1.2

2.20

6.81

u/ml

—

108

(3007164) IgA [Mass/volume] in Serum or Plasma

316

3146

1.01

0.02

1.4

1.3

2.61

2.74

g/l

0.54

186

1736

(3006442) Creatine [Moles/volume] in Serum or Plasma

137

0.95

0.01

1.2

2.0

84.62

94.16

umol/l

0.67

137

(3003740) Influenza virus B Ag [Presence] in Specimen

147

0.95

0.01

1.1

—

(3015736) pH of Urine

822

8233

1.00

0.01

3.4

3.6

5.56

5.82

1.42

335

(3011288) Drugs identified in Urine by Screen method

126

0.95

0.00

1.1

2.7

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

124

1233

1.01

0.00

2.6

2.5

—

(3037121) Protein [Mass/volume] in Urine

716

0.99

0.00

1.9

2.6

0.27

0.31

g/l

0.19

238

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

110

1099

1.00

0.00

1.5

1.6

1.65

1.52

g/l

0.77

933

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

252

0.99

0.00

1.2

155.35

212.16

miu/ml

—

(40757373) Influenza virus identified in Isolate

1.02

0.00

1.3

1.4

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

0.00

0.0

1.7

—

1.39

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3045462) Protein/Creatinine [Ratio] in Urine

0.00

-0.00

0.0

6.8

—

68.96

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

250.36

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

-0.00

0.0

10.2

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

1.34

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

-0.00

0.0

5.0

—

385.80

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

3.4

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.98

-0.00

1.4

1.2

138.25

168.13

mmol/24h

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

-0.00

0.0

3.7

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.3

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

-0.00

0.0

4.2

—

23.60

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.98

-0.00

9.8

7.3

—

(3042517) Benzodiazepines panel - Urine

0.00

-0.00

0.0

1.2

—

(3030313) Adrenal Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(40758292) HTLV I+II Ab panel - Serum

0.00

-0.00

0.0

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.93

-0.00

10.6

7.4

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

0.00

-0.00

0.0

1.7

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.8

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

10.18

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.90

-0.00

1.4

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

5.60

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

2.2

—

2.37

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

-0.00

0.0

1.0

—

(3017509) Phencyclidine [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

-0.00

0.0

1.2

—

1.24

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.96

-0.00

1.2

1.6

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.6

—

2.66

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_PANCREAS – Malignant neoplasm of pancreas

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of pancreas

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant neoplasm of pancreas (C3_PANCREAS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints